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At equilibrium, empty ribosomes freely transit between the rotated and un-rotated 
states.  In translation elongation, the binding of two translation elongation factors to the 
same general region of the ribosome stabilizes them in one of the two extremes of 
intersubunit rotation; rotated or unrotated.  These stabilized states are resolved by 
expenditure energy in the form of GTP hydrolysis.  Here, mutants of the early assembling 
integral ribosomal protein uL2 (universal L2) are used to test the generality of this 
hypothesis. A prior study employing mutants of a late assembling peripheral ribosomal 
protein suggested that ribosome rotational status determines its affinity for elongation 
factors, and hence translational fidelity and gene expression. rRNA structure probing 
analyses reveal that mutations in the uL2 B7b bridge region shift the equilibrium towards 




ribosome. Shift in structural equilibrium affects the biochemical properties of ribosomes: 
rotated ribosomes favor binding of the eEF2 translocase and disfavor that of the 
elongation ternary complex.  This manifests as specific translational fidelity defects, 
impacting the expression of genes involved in telomere maintenance. A model is 
presented here describing how cyclic intersubunit rotation ensures the unidirectionality of 
translational elongation, and how perturbation of rotational equilibrium affects specific 
aspects of translational fidelity and cellular gene expression. 
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Chapter 1: Ribosomes and Translation 
Introduction 
Protein synthesis is a complex but indispensable biological process and the 
ribosome plays a central role in it. Ribosomes are large ribonucleoprotein particles, 
conglomerates of RNA and proteins that evolved in the pre-biotic times. Mechanically 
they function like a nano-scale machine in a highly orchestrated manner in order to 
convert the genetic information from RNA to protein with tremendous speed and 
accuracy. To accomplish their tasks the ribosomes have to function in an active 
collaboration with the tRNAs and a zoo of translation factors throughout all the steps. 
Translation is an endergonic process fuelled by several ATP/GTP hydrolysis reactions. 
Recent high resolution crystal structures and Cryo-electron microscopic reconstructions 
have revolutionized our understanding of both the ribosome structure and the mechanism 
of translation in bacterial and eukaryotic systems.  
Despite the early focus on proteins, the mechanism of protein synthesis largely 
remained unclear until the end of 1940s. Some early speculations of ribosome’s existence 
were made following the development of UV absorption methods for measuring nucleic 
acids and UV microscopy. The granular nature of cytoplasm was explained by high speed 
centrifugation leading to sedimentation of what was called “small particles” from chick 
embryo cells by Albert Claude 
1,2
.They were later termed “microsomes”, smaller than 
mitochondria and their chemical composition was explained. Between 1950 and 1960, 




discovered aminoacylated tRNA in cell free systems and the microsomes got a new self-
explanatory name “ribonucleoparticle”. Sodium deoxycholate treatment displayed a 
protein: RNA ratio of 1:1. George Palade, who won a Nobel Prizefor his discovery, used 
a combination of advanced specimen preparation techniques and electron microscopy and 
was able to visualize microsomes, the electron dense particles in the cytoplasm and on 
endoplasmic reticulum
3
.These macromolecules were further calibrated using velocity 
sedimentation and electrophoretic mobility
4
. These electron microscopic images of the 
“microsomes” were the first visual insights into the ribosome structure and they helped in 
constructing the first three dimensional models of ribosomal subunits that were later 
established. During 1950s RNA-containing particles attracted more and more attention. 
Around 1955, RNA was agreed to be providing template upon which amino acids were 
assembled into protein threads. In 1958, Howard Dintiz coined the term ‘ribosomes’ for 
the first time. From 1960s onwards was marked the “golden age of translation” research. 
Research on mRNA, components of the ribosome and investigation into stages in 
translation emerged. Biochemistry of protein synthesis became the focus of molecular 
biology and in vitro systems remained central to the field but the procedures changed. 
With the advent of atomic resolution crystal structures of ribosomes, the translational 
research took off like never before. 
Ribosome Structure 
Ribosomes are universally composed of two subunits: a large subunit (50S in 
bacteria, and 60S in eukaryotes) and a small subunit (30S in bacteria, and 40S in 




electron microscopic techniques in 1980s. From these investigations, the structure of 30S 
subunit is explained as consisting of a head, connected by a neck to a body with a 
shoulder and a so-called platform. The 50S subunit was described as having a more 
compact structure. It has a rounded base with three almost cylindrical extensions (figure 
1). The three protuberances as seen from the interphase between the two subunits are 
called the L1-stalk, the central protuberance and the L7/L12 stalk. Introduction of single 
particle cryo-electron microscopy (cryo-EM) images marked a leap in achieving high 
resolutions ribosome structures. With improved resolution, details like the beak and toe 




Structural studies of bacterial 70S ribosomes namely, the Thermus Themophilus 
SU
7,8
, Haloarcula marismortui and Deinococcus radiodurans LSU
9,10
, and E.coli and 
T.thermophilus 70S ribosomes. Crystal structure of the ribosome at 5.5 A resolution
11–13
 
have pioneered in the field of high resolution X-ray crystallography studies of 
translational apparatus. They have revealed the complex architecture resulting from the 
network of interactions connecting the ribosomal(r)-proteins with each other and 
ribosomal RNA (rRNA).  
In contrast to their bacterial counterparts, eukaryotic ribosomes are much larger 
and more complex. They contain additional rRNA called expansion segments, additional 





Figure 1 Free hand drawings of the three-dimensional consensus model of the 
ribosome in 1980s.  
The ribosome consists of two asymmetrically shape subunits. The shape of small subunit 
includes a head, a base and a platform. The large subunit has a central protuberance, 
flanked by stalks (L1 and L7/L12) on both sides. Figure adopted from Lake (1985)
14
 
Eukaryotic ribosomes contain >5,500 nucleotides of rRNA (18S, 25S, 5S and 
5.8S) and 80 proteins (79 in yeast). Initially, the structure of eukaryotic ribosome was 
also explained using cryo-EM maps fitted with structures of bacterial and archaeal 
subunits
8,9
; which led to the placement of 46 eukaryotic proteins with bacterial/archaeal 
homologs as well as many expansion segments (ES)
15,16
. Subsequent cryo-EM 




proteins homologs, eukaryote-specific r-proteins and additional ESs 17–20. However , the 
full assignment of r-proteins in yeast and fungal ribosomes , became possible only with 
the high resolutioncrystal structures of SSU and LSU of Tetrahymena thermophile 21,22 
and Saccharomyces cerevisiae 80S ribosomes 23. 
The overall structures of the two subunits are preserved in eukaryotes. Addition of 
extra rRNA and r-proteins however, results in a more complex 3.6KDa ribonucleoprotein 
particle. The major difference between the bacterial and eukaryotic rRNA lies in the 
presence of five ESs (ES3S, ES6S, ES7S, ES9S and ES12S) and five variable regions 
(VRs) (h1, h16, h17, h33, h41) on the SSU, as well as 16 ESs (ES3L, ES4L, ES7L, ES9L , 
ES10L, ES12L, ES15L, ES19L, ES20L, ES24L, ES26L, ES27L, ES31L, ES39L and ES41L) 
and two VRs (H18-18 and H38). Most ESLs are present on the back and sides of the 
particle in LSU, particularly behind the P-stalk (ES7L and ES39L), behind the L1-stalk 
(formed by the clustering of ES19L ES20L ES26L ES31L) and the flexible ES27L; leaving 
the subunit interphase, the core and the exit tunnel unaffected18,19,21,23. On the SSU, 
majority of the additional rRNA comprises of ES3S and ES6S, which cluster together to 
form an additional feature on the SSU called the “left foot”19,22,23.  
35 of the 79 yeast ribosomal proteins have bacterial or archaeal homologs, 
whereas 32 only have archaeal homologs and thus 12 r-proteins of yeast are eukaryote 
specific. Cytoplasmic ribosomes of Tetrahymena and higher eukaryotes contain an 
additional r-protein, L28e. Together with the ES, the additional r-protein mass also 





Figure 2 Architecture of the 80S ribosome. Location of ribosomal Proteins 
 (A) Interface or “front” view of the 60S subunit (left) and 40S subunit (right). Landmarks 
include head, body (Bd), and platform (Pt) of 40S as well as central protuberance (CP), 
L1 stalk, and P stalk of 60S. (B) Solvent-side or “back” view of the 60S and 40S subunits. 
Figure from Ben-Shem et al.23 
Most of the conserved r-proteins have extensions which can establish long-
distance interactions up to 100 Å from the globular core of the protein (S5, L4, L7 and 
L30). Most of the additional protein mass is also located in a ring around the back and the 




conserved proteins interact with expansion segments to make the extra LSU mass. In the 
SSU, most of the eukaryote specific r-proteins and expansion segments are concentrated 
to the back of the SSU particle, forming a web of interactions with each other as well as 
other r-proteins and rRNA. The beak of the SSU acquired three r-proteins, S10e, S12e, 
and S31e.  R proteins also interact with the expansion segments through S4e, S5e, S7e 
and S8e. The long carboxy-terminal of S6e is thought to be involved in recruitment of 
specific regulatory factors22. Differences are observed in the mRNA exit site. rRNA 
features in bacterial ribosomes are also replaced by r-proteins in eukaryotic ribosomes. 
Distinct elements found within the 5’ untranslated mRNA region and divergence from the 
bacteria in initiation phase of translation can be explained by the change in ribosomal 
architecture.  
During translation, ribosomes undergo a number of conformational 
rearrangements. These changes involve intersubunit rotation and swiveling of SSU. The 
interactions between two ribosomal subunits are called intersubunit bridges that change 
with each conformational rearrangement, and are therefore dynamic in composition. The 
bridges in eukaryotic ribosomes have been mapped using cryo-EM and X-ray 
crystallographic tmethods19,20,23. Unlike bacterial ribosome that preferentially adopts 
unrotated state; the eukaryotic ribosome seems to prefer the rotated state23,25–27. The 
surface interactions at the intersubunit region between the two subunits are nearly twice 
in number as compared to the bacterial 70S. These additional bridges appear at the 






Figure 3 Yeast 80S ribosome structure.  
(A) Solvent side of both subunits: Abundance of eukaryote-specific elements in red. (B) 
Views of the 40S and 60S from back through the peptide exit tunnel. Eukaryote-specific 
protein moieties are in yellow, rRNA expansion segments in red and the conserved core 






Figure 4 Intersubunit bridges of ribosomal subunits.  
Subunit Interface showing residues forming eukaryote-specific bridges in red and 
conserved ones in blue. 
The binding sites for aminoacyl tRNA (A site), peptidyl-tRNA (P-site) and 
deacylated tRNA (exit or E-site) are predominantly composed of rRNA, which is 
conserved in eukaryotic ribosomes, suggesting that the mechanism of tRNA selection is 
also conserved28,29. Many r-proteins also encroach into the tRNA binding sites and appear 
to play important roles in a slight variation in steps like tRNA accommodation, decoding 
and translocation in eukaryotes23,30. At the peptidyltransferase center (PTC) in the LSU, 
the CCA ends of tRNAs are stabilized through interactions with highly conserved (in 
sequence and structure) A- and P-loops of the 25S rRNA, suggesting that the mechanism 
of peptidyltransfer is also conserved. However, variable specificity for antibiotic binding 
between eukaryotic and bacterial ribosomes has indicated subtle differences in their 
PTCs. These differences are likely to be arising due to the r-proteins. The interactions of 
E-site tRNA CCA-ends with the ribosomes are also altered because of replacements of 





Figure 5 tRNA and elongation gactor binding sites on ribosomes. 
A. Ribosomes with three tRNAs bound to A-site, P-site and E-sites in green, blue and 
red. mRNA in yellow. B. Ribosome with tRNAs bound in P and E-sites and EF-G in 
factor binding site. Figures prepared in pymol from atomic resolution crystal structures of 
T.thermophilus ribosomes11,31. 
As the nascent peptide chain (NC) is being synthesized, it passes through the 
tunnel in the LSU and emerges on the solvent side of it. The dimensions of exit tunnel are 
universally conserved (80Å long and 10-20Å wide), as shown by the cryo-EM 
reconstructions and X-ray crystallography structures10,21,23,32–34. It is predominantly 
composed of core rRNA with an overall electronegative charge. Extensions of r-proteins 
L4 and L22 contribute towards formation of a constriction in the tunnel where it narrows. 
In eukaryotes and archaea, L39e has replaced bacterial-specific extensions of L23 near 
the exit of the tunnel10,32. In contrast to its previously suspected role of being a passive 
conduit for the NC, growing evidence indicates that the exit tunnel plays more active 




the exit tunnel can also have effects on downstream events such as recruitment of the 
chaperones. 
Ribosome biogenesis and assembly 
In order to maintain a turnover of about 2000 ribosomes per minute36,  rapidly 
growing yeast cells have to devote a significant fraction of their resources for ribosome 
synthesis and the membrane trafficking involved.  All three RNA polymerases 
participate; RNA polymerase (Rpol) I and III transcribe the rRNAs and about 60% of the 
transcripts produced by RNA polymerase II encode r-proteins or ribosomal assembly 
factors.  Majority of the molecular transport going across the nuclear membrane also 
comprises of the r-proteins and the assembly factors entering the nucleus and the pre-
ribosomes exiting the nucleus. More than half of the introns removed by the splicing 
machinery in yeast occur in the r-protein coding mRNAs37. 
 
Figure 6 Yeast chromatin spreads of eukaryotic nucleolar contents analyzed by 




Transcription of rDNA repeats can are visualized here as “Christmas trees”; the rDNA 
depicts the tree trunk, extending rRNA depict branches and then nascent RNPs are the 
knobs at the branches depicting the ornaments. Figure from Woolford and Baserga 
(2013)37,38 
Transcription of Pre-rRNAs 
Ribosome biogenesis takes place in the non-membrane bound compartment of the 
cell nucleus called the nucleolus. The nucleolus is formed around the ~150 tandem rDNA 
repeats found on chromosome XII and is defined by the extent of ongoing transcription 
by Rpol I for ribosome biogenesis39. Rpol I maintains an elongation rate of 40-60 nt/sec40 
and accounts for 60% of total cellular transcription in yeast. The holoenzyme has 14 
subunits most of which are either shared or homologous to the subunits of RNA 
polymerase II or III. Its recruitment to the rDNA is regulated by general transcription 
factors like UAS-upstream activity factor (UAF), TATA-binding protein (TBP), core 
factor (CF) and Rm3. The rRNA synthesis step is regulated by transcription initiation and 
the ratio of active to inactive rDNA repeats41,42. During growth of S.cerevisiae, the 
number of active rDNA genes decreases from growth to stationary phase.  
Transcription of 35S primary transcript by Rpol I generates an initial 6.6 kb pre-
rRNA, which includes RNA sequences destined for 18S, 5.8Sand 25S and also the 
additional 5’externally transcribed spacer (5’ETS), internally transcribed spacers 1 and 2 
(ITS1 and ITS2), and a 3’ externally transcribed spacer (3’ETS). The 5S rRNA is 




Processing, folding and modification of Pre-rRNA 
The four spacers contained in the pre-rRNA transcript are removed by 
endonucleolytic and exonucleolytic processing. RNase III endonuclease Rnt generates 3’-
end of the primary PreRNA 35S to begin the processing. Cleavage of either of the 5’ETS 
or ITS1 at one of the sites amongst A0, A1 and A2 can occur first generating 33S, 32S and 
20S+27SA respectively. Cleavage at site A2 in ITS1 splits the pathway for pre-rRNA 
processing and subunit maturation. Optionally, there can be a separating cleavage in the 
site A3, 23S and 27SA2 pre-rRNAs. The 20S pre-rRNA is packaged in 43S particles and 
27S pre-rRNA is assembled into 66S pre-RNPs. The 43S pre-RNPs are exported from the 
nucleolus through nucleoplasm to the cytoplasm where the 20S pre-RNA undergoes final 
endonucleolytic cleavage at site D to remove the remaining ITS1 segment.  
However, the maturation 66S pre-ribosomal particle is more complex and takes 
longer. 27SA2 pre-RNA processing continues in the nucleolus in two alternative ways; 
about 85-90% of 27SA2 Pre-rRNA is shortened to 27SA3 form by endonucleolytic 
cleavage and finally the remaining ITS1 spacer is removed by 5’-3’ exonuclease to form 
27SBS, while the other10-15% of 27SA2 pre-RNA undergoes direct endonucleolytic 
cleavage at the B1L site to generate 27SBL pre-rRNA. 27SBS and 27SBL undergo similar 
identical endonucleolytic cleavage at the site C2 in ITS2 to generate 25.5S and 7SS or7SL 
pre-RNAs. The 5’ end of the 25.5S-preRNA is trimmed by Rat1 endonuclease to 
generate mature 25S. The 3’ ends of 7S pre-rRNA are processed in several steps to 




The steps involved in rRNA processing in ribosome assembly are outlined in 
figure 7. However, there is not necessarily an obligatory order for the entire processing 
pathway. The apparent order of the processing reactions can be dictated by the 
availability and identification of sites. The pre-rRNA processing occurs co-
transcriptionally, which indicates that the transcriptional precedence of sequences can 
decide the order of steps in processing. Pre-rRNAs undergo heavy modification, largely 
in the form of 2’-O-ribose methylation or pseudouridylation. These modifications can 
take place co-transcriptionally with the help of snoRNPs. snoRNPs are composed of 
snoRNAs and  several protein components, amongst them are enzymes that catalyze 
nucleotide modification.  
Ribosomal proteins play important role in subunit assembly. R-proteins and 
assembly factors bind to the 35S pre-RNA from the very start. Binding of r-proteins is 
thought to stabilize the correctly folded rRNA. Binding of r-proteins alters rRNA 
structure locally and distally to create binding sites for subsequently joining r-proteins, or 
to trigger conformational switch required for spacer removal37. The pre-rRNA spacer 
sequences can form alternative conformers by base-pairing with the sequences destined 
to be retained in mature ribosomal subunits. In addition to r-proteins ~200 assembly 
factors participate in ribosome biogenesis. Among these proteins are the endo- and 
exonucleases required for pre-rRNA processing, enzymes that modify rRNA or r-
proteins, RNA helicases/ATPases, AAA ATPases, GTPases, kinases and phosphatases, 





Figure 7. Yeast pre-rRNA processing pathway.  
The 35S pre-rRNA synthesized by RNA Polymerase I contains sequences for 18S, 5.8S 
and 25S rRNA, flanked and separated by internal and external transcribed sequences. 
Spacer sequences are removed from the pre-RNA by endo- and exonucleolytic 
processing. The 5S rRNA is transcribed by RNA polymerase III and incorporated into the 
66S pre-RNP. 
Nuclear export of Pre-40S and Pre-60S particles 
In rapidly growing yeast cells preribosomal particles are transported through each 
nuclear pore at a rate of one per 2-3 seconds36. The yeast cells need to overcome 
challenges like navigating the preribosomes with hydrophilic surfaces through the 
nucleoporins containing hydrophobic mesh of FG repeats and avoiding the export of 




export machinery, that include the nuclear export receptor Crm1, Ran GTPases and 
several nucleoporins are necessary for export of nascent ribosomal subunits in yeast43–45. 
Depletion of many r-proteins also affects the nuclear export of pre-ribosomal particles 
either directly by hampering the recruitment of export adaptors or indirectly by blocking 
assembly or failure to recycle export factors back to the nucleus. During late steps in 
nuclear assembly, mechanisms of “structural proofreading” are used by cells to ensure 
quality control and segregate only correctly assembled preribosomal subunits for export.  
 
Figure 8 Preribosomal maturation pathway to form 40S and 60S ribosomal 
subunits.  
Sequential assembly intermediates are shown, distinguished by pre-rRNA processing 
intermediates. Most r-proteins and assembly protein associate with the pre-RNPs in the 
early stages of assembly. Some bind in the middle stages and others in the late assembly.  




Cytoplasmic maturation of Pre-40S and 60S subunits 
Newly admitted nascent 40S and 60S subunits complete their maturation to 
functional subunits in several steps in order to overcome challenges of last stage of 
assembly like: 1. Assembly of last r-proteins, and release and recycling of several 
assembly factors. 2. Preventing premature association of newly exported, but yet inactive 
subunits with the translation machinery. 3. Inspection of the functional domains for their 
correct assembly 
R-proteins assembled into the pre-60S subunit before maturation includes L10, 
L24, L29, L40, L42, P0, P1, and P2. NTPases like Drg1, Efl1, and Lsg1 are present on 
cytoplasmic pre-60S subunits. These factors need to be released and recycled back into 
the nucleus for early assembly of new ribosomes. Pre-40S subunit exported to the 
cytoplasm lacks r-proteins S10 and S26 and retains seven assembly factors which are 
well-positioned to shield pre-40S subunit from premature association with the translation 
initiation machinery. Pre-60Ssubunits are prevented from participating prematurely in 
translation by blocking their association with 40Ssubunits. This is achieved by the 





Figure 9 Late Steps of maturation of Pre-60S subunits in cytoplasm.  
A bulk of nuclear assembly factors is released from 66S preribosomes in the cytoplasm 
by ATPase Drg1, GTPases Efl1 and Lsg1, and factors like Sdo1. Few last r-proteins like 
L24 and P0 are assembled and replace their nuclear homologues. 
Surveillance and Turnover of misassembled ribosomes 
In order to prevent the accumulation of malfunctioning ribosomal particles 
resulting from misassembled pre-ribosomes, mechanisms of destruction of such faulty 
subunits is of crucial importance to the cell. Exonucleases in the exosome complexes are 
functional in turnover of the aberrant pre-rRNA processing intermediates51,52.  It is not 
clear how improperly assembled preribosomes are recognized. However several 
mechanisms like turnover machinery present in the preribosomes, a hypothesized kinetic 
proofreading mechanism or a role of the 19 DEAD-box ATPases have been proposed to 





Once properly assembled and after passing through a strict quality control, the 
two ribosomal subunits can begin synthesizing proteins by adding amino acids to the 
growing peptide chain at the rate of 60s-1 and accuracy of 1 error per 104 incorporations53. 
Ribosomes accomplish the task of protein synthesis by decoding the mRNA one codon at 
a time with the help of matching charged tRNAs and other associated translation factors. 
Ribosomes go through three distinct phases of translation called initiation, elongation and 
termination. After completing the initiation step, as the ribosomes move on to decode the 
rest of the mRNA in elongation, new ribosomes can start initiation and begin protein 
synthesis. Thus, at any given time there can be several ribosomes synthesizing proteins 
on the same mRNA forming polysomes. Translation terminates when ribosomes 
encounter stop codon and release the polypeptide chain. Peptide release is followed by a 
much less understood ribosome recycling step which results in separated ribosomal 
subunits ready for a new round of translation. Structural differences between bacterial 
and eukaryotic ribosomes have led to differences in mechanism of translation as well. 
While the elongation step is mostly conserved, significant differences lie between 
bacterial and eukaryotic translation initial and termination steps. 
Initiation 
Initiation of translation is the rate limiting step in protein synthesis. It requires a 
steady supply of ribosomal subunits, initiator tRNA, mRNA and a long range of initiation 




basic outline of eukaryotic cap-dependent initiation pathway. Translation initiation begins 
with identification of initiation codon by the translation machinery.  
The first step is formation of ternary complex (TC) composed of initiator 
methionyl-tRNA (Met-tRNAi) and the GTP-bound form of eukaryotic initiation factor 2 
(eIF2); which then binds to the small (40S) subunit to form the 43S pre-initiation 
complex (PIC). In yeast, eIFs 1, 1A, 5 and eIF3 form a multifactor complex with TC, 
resulting in a network of physical interactions linking them all together and promoting 
TC binding to the 40S54.  
Equipped with the MFC, 43S PIC is now ready to bind to the mRNA near the 5’-7 
methylguanosine cap in a process facilitated by the eIF3, the poly(A) –binding-protein 
(PABP), eIFS 4B, 4H and 4F. The eIF4F complex comprises of, cap-binding protein 
eIF4E, RNA helicase eIF4A, and scaffold protein eIF4G that harbors binding domains for 
PABP, eIF4E, eIF4A, eIF3 and RNA. This enables eIF4G to coordinate interactions with 
mRNA via the cap, poly(A) tail, and sequences in the mRNA body to assemble a stable, 
circular messenger ribonuclearprotein (mRNP), referred to as the “closed loop” structure. 
The helicase activity of eIF4A is thought to generate a single stranded landing platform 
on the mRNA where the 43S PIC loads with the help of stimulating interactions between 





Figure 10 Cannonical eukaryotic translation initiation pathway.  




After binding near the cap, the 43S PIC scans the mRNA leader sequence for an 
AUG start codon in a suitable context56,58. Start codon recognition occurs by base-pairing 
between the AUG codon and Met-tRNAi anticodon in the P site of the 40S subunit 
causing arrest of scanning PIC and triggering conversion of eIF2 in the TC to its GDP 
bound state via gated Pi release. Following GTP hydrolysis, the eIF2·GDP is released 
from the PIC and must be recycled to eIF2·GTP for renewed TC assembly through a 
reaction catalyzed by the hetero-pentameric guanine exchange factor (GEF) eIF2B. After 
the start codon has been recognized, the remaining factors must dissociate from the 
complex and the 60S subunit must join the 40S subunit to form the final 80S initiation 
complex (IC) with Met-tRNAi and start codon in the P-site ready to begin the elongation 
phase of protein synthesis55,56. Subunit joining is facilitated by a second GTPase initiation 
factor eIF5B59. Interactions of the initiation factors with each other, with the ribosome, 
mRNA and tRNA have been characterized in detail using mutational analysis, high 
resolution X-ray crystallography, cryo-EM, hydroxyl radical mapping and toe printing 
experiments60–65. Additional structural studies are still required to fully elucidate the roles 
of different initiation factors in conformational transitions associated with scanning, start 
codon recognition and subunit joining. 
Viral Hijack of translation initiation 
Viruses are obligate intracellular parasites, and their replication requires 
exploiting the host cellular functions. Lacking their own translational apparatus, they 




proteins required for their replication. Viruses employ variety of strategies to exploit the 
translation machinery to their advantage and impairing the translation of host mRNAS.  
One of the strategies is to impair the host translation initiation called “host shut-
off”, while the viral protein synthesis proceeds via an alternate initiation mechanism 
relying on cis-acting RNA elements. Some viruses do this directly. Poliovirus (an 
enterovirus), feline calcivirus and retroviruses encode proteases that can cleave eIF4G, 
rendering it non-functional and impairing the host translation initiation66–68. Enterovirus 7 
infection induces miRNA expression which reduces eIF4E abundance, while Vesicular 
stomatitis virus, influenza virus and adenovirus reduce the phosphorylation levels of 
eIF4E, hampering host translation69. Some viruses impacts indirectly like 
Encephalomyocarditis virus infection causes inactivation of 4E-BP, a protein that 
indirectly affects translation initiation70. In influenza virus, hantavirus and yeast L-A 
virus infections, a unique phenomenon called “cap-snatching” occurs, where m7GTP caps 
on the viral RNAs are derived from host mRNAs, inducing viral but inhibiting cellular 
translation71–7371–73. 
Cap-independent translation is a implemented in some viral mRNAs to 
circumvent host defense. For e.g. in Calcivirus has the VPg, a virus-encoded protein is 
covalently attached to the 5’ end of their RNA genome instead of m7GTP. The VPg can 





Figure 11 Alternate ways of recruitment of 40S ribosomal subunit to viral mRNAs.  
Borrowed from Walsh D et al. Cold Spring Harb Perspect Biol (2013)7474. 
Several viruses contain internal ribosomal entry sites (IRESs) within their 5’ 
untranslated regions that directs initiation through interactions with eIFs or r-proteins75. 
IRES dependent translation initiation may require no initiation factors at all. Various 
classes of IRESs have been described as shown in figure 11. The complicated structures 




overcomes the rate limiting step of initiation and thus the cap-independent translation of 
IRES containing messages can proceed. Recently IRESs have been discovered in 
important cellular mRNAs coding proteins like Bip, p53, c-myc, VEGF, ornithine 
decarboxylase etc. In the events of stress or starvation when the cap-dependent cellular 
translation is shut down, IRES mediated translation goes on and at times even favored. 
 
Figure 12 The eukaryotic translation elongation pathway.  





Once the ribosome is stably localized on the mRNA at the end of initiation phase, 
elongation cycle starts proceeding very fast adding one amino acid at a time to the 
growing peptide chain. The mechanism of elongation is well conserved between 
eukaryotes and bacteria77. Elongation cycle is the fastest phase of translation and most 
thoroughly studied as well. Summarized below is the current understanding of the key 
steps in translation elongation cycle. 
Aminoacylation and accommodation of tRNAs  
Aminoacy-tRNA binding as a ternary complex with eukaryotic elongation factor1 
(eEF1) and GTP to the A-site of the 80S initiation complex is the first step of translation 
elongation. However, even before it binds to the A-site, the tRNA molecule has to be 
charged with its cognate amino-acid in a two-step reaction catalyzed by a class of 
enzymes called aminoacyl-tRNA synthetases (ARS). First, the enzyme activates the 
cognate amino acid by condensing it with ATP to form a transient molecule, aminoacyl 
adenylate (AA-AMP) that remains bound to the enzyme’s active site ready for the second 
reaction catalyzed by ARS resulting in formation of an ester linkage between the 
carboxyl group of amino acid and a hydroxyl group of the terminal 3’ adenosine of the 
tRNA. Cells require at least 20 synthetases, one for each of its amino acids. The 
aminoacyl tRNA synthetases are the actual translators of genetic code. Their faithful 
recognition of cognate tRNA depends upon specific interactions between the proteins and 
identity elements present in tRNA sequences and structures, which are located not only 




exceptions, all aminoacyl tRNA synthetases with the same amino acid specificity are 
orthologs and most individual synthetases have been conserved throughout speciation 
events and predate the separation of three kingdoms of life. In addition to their 
aminoacylation activity, several subclasses of ARSs (e.g. Valyl-, leucyl,- and isoleucyl 
tRNA synthetases) possess an editing activity to prevent misacylation (resulting from 
activation of stereochemically similar amino acids81 of their cognate tRNA. This editing 
domain that catalyzes the hydrolysis of noncognate aminoacyl adenylates or misacylated 
tRNAs, is inserted into the catalytic domain for aminoacylation, creating a separate active 
site82,83. 
For high efficiency of translation, the ARSs stay in close proximity to the 
ribosome. Recent evidence has shown that mSerRS and ArgRS interact directly with 
archaeal ribosomes suggesting a mechanism of tRNA recycling in which ARSs associate 
with the L7/L12 stalk (P0/P1 stalk in eukaryotes) region to recapture the tRNA released 
from the preceding ribosome in polysomes84. A similar mechanism is suggested by a 
study on ribosome associated protein Scp160p which might increase the efficiency of 
tRNA recharging, or prevent diffusion of discharged tRNAs85. Specificity of 
aminoacylation by ARSs, plus their editing capacity and their maintenance in the specific 
codon niche near the translating ribosomes adds to the efficiency and accuracy of 
translation. ARSs serve as a potential target for translation control. In bacteria, ARSs 





Figure 13 The domain structure of LeuRSEC.  
Residue numbers indicate domain boundaries. The color code used throughout this paper 
for the various domains is as follows: yellow, catalytic domain; purple, ZN1 domain 
(zinc ion in green); cyan, editing domain; pink, leucine-specific domain; red, anticodon-
binding domain; orange, C-terminal domain. (b) Aminoacylation conformation with the 
tRNA in green. (c) Editing conformation with the tRNA in blue. In this state, the ZN1 
domain is partially disordered87. 
A correctly charged tRNA forms ternary complex with eukaryotic Elongation 
Factor 1 (eEF1) and GTP, in order to get delivered to the A-site of the ribosome for 
translation to proceed. Details of tRNA accommodation are pictorially explained in figure 
14. The eukaryotic Elongation Factor 1 (eEF1) comprises eEF1A, which delivers aa-
tRNA to the ribosomes and eEF1B, which acts as a Guanine exchange factor (GEF) 
composed of two subunits eEF1B and eEF1. eEF1A is  a member of GTPase 





and then directs tRNA to the A-site of the ribosome. Codon recognition by the tRNA 
completes the accommodation triggering GTP hydrolysis by eEF1A, releasing the factor 
in complex with GDP as a result of conformational change. The spontaneous rate of GDP 
dissociation from these factors is slow and the GEF is required to recycle the inactive 
GDP-bound factor to its active GTP bound state. eEF1B subunit of eEF1B inserts an 
essential lysine residue into the Mg+ and -phosphate binding site to destabilize Mg+ 
binding leading to GDP release77,88. 
Ternary complex binding to the ribosome is a two-step process. Initial binding or 
sampling of the ternary complex is the first step in tRNA accommodation, and it results 
in transient interactions of the ternary complex with elements composing the A-site and 
placement of the anticodon in the decoding center of the small subunit. Base pairing 
between the mRNA codon and tRNA anticodon forms the final basis of cognate (or 
sometimes near-cognate) tRNA selection, rejecting non-cognate ternary complexes 
quickly and efficiently. Codon-anticodon interaction leads to the formation of a small 
helix leading to changes in its local environment, such as flipping of 18S rRNA bases 
A1755, A1756, and G577 from syn to anti-conformation89. Accompanying 
conformational changes lead to the activation of eEF2 GTPase center. Recent high 
resolution structures of bacterial ribosomes bound to EF-Tu and aminoacyl-tRNA have 
shown that tRNA anticodon stem suffers structural distortion between the acceptor and 
the D-stems, allowing it to interact with the decoding site on the small subunit and EF-
Tu. It is believed that the codon-anticodon base-pairing occurring only in case of cognate 




tRNA can energetically allow such a distortion in tRNA, thus promoting high fidelity 
decoding29,90. 
 
Figure 14 Schematic of EF-Tu-dependent aa-tRNA binding to the A site. 
 Two step recognition of cognate tRNA by the ribosome. Various steps in tRNA 
accommodation, represented by forward and reverse rate constants were measured by 
rapid kinetics or single molecule FRET by Geggier et al. and Blanchard et al.91,92 Figure 
from  Wohlgemuth et al.93 
The next step in tRNA accommodation, “kinetic proofreading”, which happens 
after irreversible GTP hydrolysis reaction, ensures the high fidelity of translation94. The 
initial selection of tRNA offers comparatively little discrimination between the cognate 
and near cognate tRNAs; it the proofreading step comprising of conformational changes 
following the codon-anticodon base-pairing, causing an induced fit of cognate tRNA in 




tRNA reaction. Near cognate tRNAs fail to cause such an induced fit and can be rejected 
even after GTP hydrolysis94. It has been shown that in addition to lower dissociation rates 
cognate tRNAs also have higher forward rates for GTPase activation and tRNA 
accommodation compared to near-cognate tRNA95. The two kinetic steps in tRNA 
accommodation work in concert contributing towards cognate tRNA selection and 
translational fidelity. 
Peptityltransfer Reaction 
As soon as the aa-tRNA is fully accommodated into the A-site, amino-acyl end of 
the tRNA enters the peptidyltransferase center,  peptide bond formation occurs rapidly 
and spontaneously96. Nucleic acids were not believed to be capable of catalytic activity 
until the discovery of catalytic RNA97,98. Despite evidence hinting towards it, rRNA was 
not thought to catalyze peptidyltransferase reaction; instead ribosomal proteins were 
implicated in catalyzing the reaction. Later, biochemical evidence for the role of 23S 
rRNA in peptidyltransfer started to accumulate 99. 50S subunits from Thermus aquaticus 
retained most of their peptidyltransferase activity even after losing 80% of its constituent 
protein100. Some of the proteins, like L2 and L3 required for reconstituting the 
peptidyltransferase activity in-vitro were earlier thought to have the enzyme activity; but 
later it was shown that these proteins are responsible for maintaining the structural 
integrity of ribosomal rRNA essential for trapping the tRNA reducing the entropy penalty 
for peptidyltransferase reaction. The peptidyltransferase center on the large subunit is 
built up of highly conserved rRNA elements; thus the reaction mechanism is also very 




site and P-site substrates align stably and precisely in the active site because of their 
conserved CCA ends and -amino groups interacting with the residues of 23S rRNA in 
the active site. The chemistry of peptide bond formation is explained in figure 15. Peptide 
bond is formed by nucleophilic attack on the ester carbonyl group of peptidyl-tRNA in 
the P-site by the -amino group of aa-tRNA bound to the A-site of PTC.  
 
Figure 15 Schematic of peptide bond formation on the ribosome.  
The -amino group of the amino-acyl tRNA in the A-site (red) attacks the carbonyl 
carbon of  peptidyl tRNA in the P-site (blue) resulting into formation of one amino acid 
longer peptidyl tRNA in the a-site and deacylated tRNA in the P-site101. 
The ribosome accelerates this rate by more than 106 –fold with respect to the 
unassisted reaction. Catalysis seems to involve a six-member transition state and the 
proton shuffling takes place via the 2’-OH of A76 of peptidyl-tRNA102,103 (figure 16).  
Recent studies have shown that the 2’-OH group of the A76 in the peptidyl-tRNA is 
pivotal in orienting substrates in the active site required for optimal catalysis104. A 
favorable entropy change drives the reaction; whereas the usual driving force, change in 
enthalpy remains small and unfavorable105. The ribosome provides an electrostatic micro-
environment that shields the environment from bulk water, helps in proton shuttle and 





Figure 16 Mechanism of Peptidyl transfer.  
(A) The environment of active site during peptidyl transfer: structure of PTC shows the 
proximity of the 2’-OH group of A76 to the nucleophile and leaving group to the 2’-OH 
group of A2451. (B) A six membered transition state formed during the 
peptidyltransferase reaction shows the concerted proton shuttle mechanism104,105 
Translocation 
With the completion of peptidyltransfer reactions, the peptide chain is transferred 
to A-site tRNA and covalently bound to it. Interactions of the growing peptide with the 
peptide exit tunnel anchor the acceptor end of the peptide carrying tRNA to the P-site of 
the large subunit106. Thus, as a result of peptidyltransfer reaction, peptide chain grows by 
one residue and spontaneously forces the acceptor end of the A-site tRNA to the P-site of 
large subunit and similarly the acceptor stem of the newly de-acylated tRNA is forced to 






small subunit. As a result the tRNAs assume hybrid P/E and A/P states leading to inter-
subunit ribosomal rotation as shown in the figure 1716,107,108. Due to the formation of 
hybrid states, the tRNA molecules move with respect to the ribosomes only one end at a 
time while the other end acts as an anchor stably attached to one of the subunits. The 
classical and hybrid states of tRNAs in unrotated and rotated states of ribosomes 
respectively seem to maintain dynamic equilibrium108–110.  The event of eEF2 binding in 
complex with GTP, catches the ribosomes in hybrid state; binds to the ribosomes and 
shifts the equilibrium towards the rotated state by stabilizing or locking them in rotated 
state. The ribosomal ability to rotate and interactions of P-site tRNA with the E-site in 
large subunit are necessary requirements for eEF2 binding111,112. The next step is 
translocation of the other end; i.e. the anticodon stem loop of tRNA along with the base 
paired mRNA codon, leading to classical state tRNAs (P/P and E) and unrotated 
ribosome followed by a quick exit by the deacylated tRNA. The rotated/hybrid state of 
ribosomes is an early substrate for translocation. After EF2 binding, the GTPase center is 
activated causing the GTP hydrolysis and phosphate release. As a result, large scale 
conformational changes are induced in eEF2113,114 causing its release from the ribosome, 
coupled to phosphate release, which helps in preventing the backward movement of 
tRNAs31. Thus, eEF2 has several functions in translocation; stabilizing the formation of 
hybrid state; inducing the unlocked conformation of ribosomes and preventing the 
backward movement of tRNA.  As the eEF2 is released the subunits are locked in 
unrotated/classical post-translocation state ready for a new ternary complex to bind and 





Figure 17 Mechanism of Translocation.  
The pre-translocation state tRNAs can be in classical (A/A and P/P) state or hybrid (A/P 
and P/E) states. The formation of hybrid state correlates with intersubunit rotation. 
EFG•GTP binding stabilizes the rotated states. Rapid GTP hydrolysis drives 
conformational change in EFG and ribosome rearrangements leading to mRNA-tRNA 
translocation on SSU, and drives the pre-translocation hybrid state to post-translocation 
classical state77. 
eEF2 in eukaryotes and EF-G in bacteria promote translocation by binding to the 
ribosome and inserting domain IV of the factor into the decoding center of small subunit. 
A conserved histidine residue (His 699 in yeast eEF2) is modified to diphthamide. This 
modification is universally conserved amongst all eukaryotes but non-essential for cell 
viability115. However, it has been shown that knock-out mice lacking the ability to do the 
diphthamide modification were either embryonically lethal or showed severe 
developmental defects116–118, suggesting a critical role for diphthamide at a specific time 
during development in multicellular organisms. 
In addition to the highly conserved eEF1 and eEF2, translation elongation in yeast 
requires a fungal specific factor eEF3 that is not eesential in bacterial or other eukaryotic 




ribosomes in complex with ATP and ATP hydrolysis is required for its dissociation from 
the ribosome. eEF3 spans across on top of the two subunits and makes contact with the 
central protuberance in the large subunit and the head of the small subunit. A 
chromodomain of eEF3 binds near the E-site of the ribosome and is suspected to facilitate 
the release of deacylated tRNA from the E-site119,120.  Further genetic, biochemical and 
structural analyses are needed to determine the function and unique requirement of eEF3 
by fungi. 
 
Figure 18 Comparison of tRNA and eRF1 crystallographic structures.  
The similarity in structures of (A)tRNA and (B) eRF1 is shown by side view (left) and 




Termination and Ribosome Recycling 
When a ribosome reaches the end of coding sequence of mRNA and a STOP 
codon (UAA, UGA or UAG) enter the decoding center, termination of translation occurs 
and peptide chain is released from the tethering tRNA. There is no tRNA that can make 
base pairs with these codons. Thus translation factors that are structural and mimics of 
tRNA bind to the ribosome in the event of termination. Figure 18 demonstrates the 
structural similarities between eRF1 and tRNA. 
In eukaryotes, termination is catalyzed by two protein factors called release 
factors 1and 2 (eRF1, and eRF3) that work collaboratively in the process. The class I 
factor eRF1 is responsible for high-fidelity STOP codon recognition and peptidyl tRNA 
hydrolysis. The class II factor eRF3, is a translational GTPase and closely related to EF-
Tu and EF-G. eRF1 associates with eRF3•GTP to form a ternary complex just like the 
one in elongation cycle. Overall structure of eRF1 resembles that of a tRNA. It has three 
domains121. The N-terminal domain is responsible for codon recognition through a highly 
conserved NKS motif that is proposed to decode stop codons through codon: anticodon 
like interactions. The middle (M) domain of eRF1 is functionally analogous to the 
acceptor stem of tRNA, and extends itself into the PTC and contains a universally 
conserved Gly-Gly-Gln (GGQ) motif; mimicking the CCA end of a tRNA, essential for 
catalyzing peptidyl-tRNA hydrolysis (shown in bacteria) because of its probable 
involvement in positioning of hydrolytic water or stabilizing the transition state in the 
highly conserved RNA rich PTC of the ribosome in a way similar to that observed in 




interactions with eRF3. eRF3 has a variable amino terminal and a more conserved 
carboxyl terminal that directly interacts with the M and C domains of eRF1125–127. High 
binding of eRF1 to eRF3 promotes its recruitment to the ribosome in complex128 because 
eRF1 acts as an inhibitor of GTP dissociation from eRF3, which is unusual and entirely 
different from prokaryotes. GTP hydrolysis by eRF3 is a prerequisite for peptide release. 
GTP hydrolysis induces a rearrangement in the eRF1 binding state such that the correct 
placement of GGQ motif could trigger GTP hydrolysis. This is different in prokaryotes 
where the peptide release precedes and is required for GTP hydrolysis. The reaction 
mechanism for peptidyl tRNA hydrolysis is shown in figure 19. 
 
Figure 19 Mechanism of peptidyl-tRNA hydrolysis and Release factor mediated 
peptide release.  
Post-termination ribosomes need to be recycled to free subunits to start over again 
in translation. In bacteria, recycling is well defined and involves specialized ribosome 
recycling factor (RRF). After the RF3 stimulated dissociation of RF1/2 from the bacterial 
ribosomes, RRF in association with EFG•GTP interacts with rotated state ribosomes 




intersubunit interactions129,130. GTP hydrolysis promotes subunit dissociation; IF3 binds 
to the small subunit and stabilizes the dissociation event and promotes the release of 
deacylated tRNA and mRNA131–133. In eukaryotes there is no homolog of RRF and the 
mechanism of recycling is unclear yet appears distinct bacteria. Current evidence 
suggests that the post-termination complex consists of unrotated mRNA bound ribosomes 
with eRF1 and deacylated tRNA in A and P sites respectively134. Recently, several 
studies have identified a conserved cytosolic ATPase, ABCE1 as a likely candidate for 
promoting ribosome recycling. ABCE1 is an ABC family protein conserved in 
eukaryotes and archaea. Mechanistic insights into ribosome recycling surprisingly came 
from the studies of proteins involved no-go decay (NGD) pathway, an mRNA decay 
pathway of messages with stalled ribosomes. Dom34 and Hbs1 are functional paralogs of 
eRF1 and eRF3 in NGD135. They bind to the A-site of the ribosomal complex and 
promote subunit dissociate in a codon independent manner, and without causing peptide 
release due to the lack of the two necessary motifs, NIKS for codon recognition and GGQ 
for peptide release136–139. Dom34 dependent subunit dissociation activity is substantially 
promoted (~20 fold) by the presence of Rli1 (yeast homolog of ABCE1)140. Similar 
enhancements of ribosomal recycling are seen in in-vitro reconstituted mammalian 
systems. . Rli has also been shown to directly promote the rate of peptide release by 
eRF1•eRF3140,141. Thus the protein Rli1/ABCE1 is proposed to be playing a role similar 
to bacterial RRF such that by promoting the release activity, it can be staging the 
sequential events of termination and recycling. Deacylated tRNA and mRNA are likely to 




by Ligatin or CT-1/DENR interactions. Release of tRNA and mRNA from recycled 40S 
subunits can also be stimulated by eIF1, eIF1A and eIF3.  
Antibiotics: Inhibitors of Ribosome Functions 
 Protein synthesis is indispensable to cell cycle progression and thus 
translation serves as a fundamental cellular mechanism available for external intervention 
using much smaller molecules called antibiotics. Structural differences between bacterial 
and eukaryotic ribosomes and mechanistic differences between their translational 
processes have aided in discovery and development of clinical antibiotics specifically 
targeting bacterial translation. Being several orders of magnitude larger in size than the 
antibiotic molecules, the ribosomes and accompanying translational apparatus harbor 
multitude of drug targets. About 50% of all antibiotics are translation inhibitors. 
Antibiotics have been identified for inhibiting almost every step in translation, although 
with varying levels of specificity142,143.  
Recent high resolution ribosomal structures have demonstrated the precise 
binding sites for several antibiotics144–151. These structural studies have shown that 
antibiotics predominantly target the functional centers of the ribosomes, namely the 
tRNA-mRNA pathway on the small subunit, the PTC, the adjacent exit tunnel on the 
LSU and translation factor binding sites. Generally ribosome-targeting antibiotics tend to 
interact with rRNA with the exception of compounds like thiopeptides, streptomycin and 
spectinomycin, where r-proteins L11, S12 and S5 contribute to their respective binding 
sites. Antibiotics like edeine and sparsomycin, which bind to the highly conserved, 




However, many ribosome targeting drugs are prokaryote specific translation inhibitors. 
The target specificity appears to be conferred by biochemical differences between the 
regions surrounding the drug binding site or mutations or alterations in nucleotides or 
ribosomal proteins that do not directly interact with the drug directly but rather affect the 
nucleotides in the drug binding site indirectly. Most ribosome-targeting antibiotics are 
bacteriostatic except aminoglycosides that are bactericidal152and induce cell death by 
causing increased rates of amino acid misincorporations in proteins causing misfolding of 
membrane proteins which eventually leads to oxidative stress and cell death153,154. 
Translation initiation inhibitors: Kasugamycin (Ksg) binds to the bacterial SSU, 
30S within the path of the mRNA in two sites, first site overlapping the position of the 
first nucleotide (+1) of the P-site codon and last nucleotide of the E-site codon (at the top 
of h44 on 30S) and the second binding site in the E-site (30S). Ksg inhibits binding od 
initiator fMet-tRNAMet to the 30S P-site indirectly by perturbing the path of mRNA155.  
Edeine (Ede) also prevents binding of the initiator tRNA (tRNAi) to the 30S. It binds to 
the solvent side of the 30S platform between h23, h44, and h45 and causes unusual base-
pairing between bases at the tips of h23 and h24. As a result, Ede perturbs the path of 
mRNA, preventing the correct positioning of mRNA at the P-site and thus inhibiting the 
initiator tRNA binding156. Pactamycin (Pct) inhibits translation initiation as well as 
elongation in both bacteria and eukaryotes. It allows the binding of tRNAi, but forms 
non-functional 70S. Pct binds to a site located between h23 and h24 on 30S and mimics 
the mRNA, blocking its path. As a result it inhibits the first translocation reaction. The 




joining157. GE81112 represents a family of tetrapeptides isolated from the fermentation of 
Streptomyces sp. species. It binds to the 30S and inhibits initiator tRNA binding158. 
Inhibitors of the elongation cycle: Some antibiotics have more than one mode of 
inhibition in translation. For e.g. streptomycin and aminoglycosides inhibit translation by 
influencing translational fidelity as well as inhibiting translocation. Tertracylins prevent 
the initial binding ternary complex (aa-tRNA•EF-Tu•GTP) to the ribosome. Kirromycins 
trap the aa-tRNA•EF-Tu on the ribosome. Pulvomycin prevent ternary complex 
formation. Sterptomycina and aminoglycosides like paromomycin induce translation 
fidelity defects. Puromycin (Puro) belongs to a class of drugs that bind to the A-site of 
PTC. It mimics the 3’ end of aa-tRNA with an exception that the amino acid residue is 
linked to the ribose via an amide link instead of ester. After binding to the PTC, Puro 
undergoes peptidyl transfer accepting and covalently linking to the NC. Subsequently, the 
peptidyl-Puro is released from the ribosomes because of low affinity. Puromycin inhibits 
translation across all kingdoms, thus it is not used clinically but it has been an important 
tool for studying peptidyl transfer reaction. Hygromycin A binds to the A-site of the PTC 
and inhibits the peptidyl transfer reaction. Chloroamphenicol binds the PTC and displays 
substrate-specific inhibition. Oxazolidinones like linezolid inhibit the A-site tRNA 
accommodation. Anisomycins bind in the A-site of PTC on the LSU. Basticidin mimics 
the CC of the CCA end of a P-tRNA. Sparsomycin prevents A-site tRNA accommodation 
and enhances P-site tRNA binding. Pleuromutilions such as tiamulin bind the PTC in a 




inhibit protein synthesis by blocking the progression of nascent polypeptide chain. These 
antibiotics bind in the exit tunnel of the 50S LSU. 
Translocation inhibitors: The thiopeptide antibiotic thiostrepton perturbs protein 
synthesis by disruting the accommodation of translation factors. Fusidic acid inhibits the 
dissociation of GDP bound EFG from the ribosome after GTP hydrolysis. Alpha-sarcin 
cleaves the SRL to prevent the GTPase activation of translation factors. Spectinomycin 
stabilizes an intermediate during translocation thus preventing it from finishing. 
Viomycin blocks translocation by stabilizing the hybrid state formation.  
Bacterial cells have displayed an ever-increasing emergence of antibiotic 
resistance by adopting mechanisms like altered membrane permeability of the drug, 
mutation or modification of the drug target, overexpression and protection of the target or 
drug modification and degradation etc. (discussed in Wilson (2013))143. It is thus 
important to develop novel strategically designed drugs against the bacterial translation 
machinery.  
Antibiotics have also been useful in understanding the ribosome structure, both in 
bacteria ad in eukaryotes. Compounds like viomycin, fusidic acid, cycloheximide and 
kirromycin have aided in arresting transient intermediate complexes in the translation and 





Figure 20 Sites of antibiotic action during protein synthesis.  
Schematic diagram shows sites of action of different antibiotics during different stages of 





The bulk of translation takes place with high speed and accuracy during the 
elongation phase of translation. During canonical translation, the mRNA codons are read 
one triplet at a time aided by formation of codon-anticodon base pairs. This results in 
yielding a single polypeptide whose extension terminates as the ribosomes reach the stop 
codon. However, like any rules, the process of translation also has exceptions. A variety 
of non-canonical pathways exist that induce reading of alternate code by the ribosomes 
and synthesis of new proteins. Such non-canonical translational events are collectively 
referred to as “translational recoding”. Intrinsically the spontaneous rates of recoding are 
low161, but cis-acting mRNA elements act as inducers of recoding events. Some 
exceptions to the canonical translation include mRNA decoding in alternate frame 
(frameshifting), redirection ribosomes to initiate translation at an alternate start codon, 
and suppression of a stop codon. Most of these pathways were originally identified in 
viruses and essential for viral replication. Translation recoding pathways also have been 
shown to exist in bacterial cells. Recently, there is a growing amount of evidence 
indicating that robust translation recoding exists in eukaryotic cells and it functions in 
fine-tuning gene expression162,163.  
Programmed -1 Ribosomal Frameshifting 
The first evidence and hence most of the understanding about -1 programmed 
ribosomal frameshifting (-1 PRF) comes primarily from viruses. Viruses exploit this 
phenomenon to condense their genomes in order to be able to accommodate them 




code multiple proteins from a single unaltered mRNA. Most of the well-defined -1 PRF 
phenomena are directed by mRNA sequence motif composed of three important 
elements: a slippery site composed of seven nucleotides where the frameshift actually 
takes place, a short spacer sequence of usually less than 12 nucleotides, and a 
downstream stimulatory structure which is usually an mRNA pseudoknot164. Figure 21 
shows a typical -1PRF signal.  
 
Figure 21 A typical -1 Programmed ribosomal frameshift signal.  
It contains a heptameric slippery site, a short spacer and a mRNA secondary structure (H-
type pseudoknot here). 22 functional slippery site sequences are given. Figure from 
Dinman (2013)165. 
The slippery heptameric motif has a sequence N NNW NNH, where the incoming 
reading frame is denoted by the spaces166. According to a general notion, the complex 
downstream secondary structure causes the elongating ribosomes to pause. The slippery 
site allows the non-wobble bases of both A-site and P-site tRNA anti-codons to re-pair 
with the codons in -1 frame. While mRNA secondary structure studies have shown that 
pseudoknots are the most common -1PRF inducing structures, other mRNA structures are 




structure is to provide an energy barrier to the translating ribosomes and cause a resulting 
change in frame; once the energy barrier is overcome, the ribosomes can continue 
translating in the chosen reading frame. The thermodynamic stability of the of the 
stimulatory RNA structure is however only one of the many determining parameters for 
frameshift efficiency170. 
 
Figure 22 The mechanism of -1PRF.  
An mRNA pseudoknot forces elongating ribosome to pause over the slippery sight which 
induces frameshift by 1 base in 5’directionand repairing of A- and P-site tRNA. As the 
pseudoknot is resolved, elongation resumes in new (-1) frame. Figure from 
viralzone.expasy.org 
Several pathways and mechanistic models have been proposed in order to 
describe the order of events and the time of slippage of tRNAs in -1 PRF164,166,171.  There 




explained by more than one mechanism. It is suggested that -1PRF should be viewed as a 
problem of kinetic partitioning which occurs along the steps of elongation pathway. It is 
through kinetic partitioning indeed, recently shown that -1PRF occurs due to and during 
impeded translocation172. Recently, the general mechanistic framework of -1PRF, 
highlighting multiple kinetic branch points during elongation was explained by single 
molecule fluorescence tracking173. 
Many RNA viruses utilize -1PRF to regulate the expression of multiple genes 
encoded by their monocistronic RNA. The mRNA of these viruses contains two or more 
overlapping open reading frames (ORFs), in which the 5’ORF codes the viral 
nucleocapsid protein gene (Gag)while the second ORF in -1 frame with respect to the 
first and codes for an enzymatic protein (Pro or Pol). The Pol gene is only translated in 
fusion with the Gag protein in an event of -1PRF which occurs at a specific frequency of 
for every virus. The maintenance of specific frequency is important for achieving a 
specific ratio of Gag to Gag-pol. In S.cerevisiae L-A virus, the Gag-Pol fusion protein 
nucleates the Gag polymerization to form a viral particle. An increased ratio of 
frameshifting leads to high levels of fusion protein which act as too many nucleating 
points leading to formation of incomplete viral particles. Decrease in frameshifting, on 
the other hand may not promote efficient dimerization174. -1 PRF functions in similar way 





Figure 23 -1 Programmed ribosomal frameshift in viruses.  
Optimum extent of frameshifting is crucial for viral replication. Both increased and 
decreased levels of frameshifting results in defects in viral assembly165. 
 In coronaviruses also, -1PRF produces a C-terminally extended fusion 
peptide that is subsequently proteolytically processed. However, genes involved in -1PRF 
are involved in replicase or transcriptase function179. Optimum levels of -1PRF being so 
crucial in viral propagation, it becomes a target for antiviral therapeutics. -1PRF can ve 
intervened by mutagenizing the -1PRF signal, the host translation apparatus r by using 
small molecule inhibitors of frameshifting.  
Several functional -1PRF signals have been identified in eukaryotic mRNAs. 
Genomic –1PRFs function in a context different from the viral mRNAs. More than 95% 
of the -1PRFs that occur in cellular mRNAs, lead the elongating ribosomes to a 




mRNA decay pathways leading to an inverse relation between -1PRF and mRNA 
abundance. In Sachharomyces cerevisiae -1PRF functions as an mRNA destabilizing 
factor via both non sense mediated decay and no-go decay pathways180,181. One study 
shows that -1PRF in the EST2 mRNA encoding the catalytic subunit of the telomerase, 
acts as a destabilizing agent, and can play a role in telomere length homeostasis182. 
Another study shows that -1PRF in a human gene coding protein CCR5, also works an 
mRNA destabilizing element in mammalian cells through NMD. This -1PRF signal is 
subject to manipulation by miRNA.  
Programmed +1 ribosomal frameshifting 
 +1PRF is a much less common and much less understood event in 
translation recoding. It is also utilized by viruses and transposable elememnts to regulate 
gene expression of structural and enzymatic proteins. +1PRF is also driven by cis acting 
elements. The precise mechanisms of frameshift are different for +1PRF, but it is 
detected in human, mouse, bacterial and yeast genomes183–186. A slippery site is requires 
for +1PRF while a downstream stimulatory structure is not. While -1PRF has a more or 
less one coherent mechanism for -1PRF, +1PRF is more case dependent. +1PRF take 
place during the translation of Ty1 retrotransposable elements. The situation of “hungry 
codons” or rare codons in the A-site induces the shift of frame. Due to the lack of 
adequate amount of cognate rare codons, a near-cognate tRNA wobble-base pairs with 
skipping one base on the mRNA186. +1PRF in the OAZ is primarily driven by the 





Missense and nonsense suppression.  
Translational fidelity of elongating ribosomes can be disturbed in a way other 
than change of reading frame. This includes missense suppression (accommodation of 
near or non-cognate tRNAs mistakenly) and non-sense suppression (incorpotation of 
suppressing tRNAs at stop codons in place of release factors, thus reading through and 
continuing elongation past the stop codon). Missense suppression often occurs when the 
elongating ribosomes encounter a rare codon, thus in the lack of presence of rare cognate 
tRNA, a near-cognate or non-cognate tRNA is misincorporated. Viruses use the nonsense 
suppression strategy to make the gag-pol type fusion proteins, with the help of cis-acting 
mRNA elements in a way similar to -1PRF188,189. Nonsense suppression is also utilized as 
a method to incorporate the rare and essential 21st amino acid selenocysteine (Sec) in 
cellular protein in all three kingdoms. It requires specific trans-acting elements and 
mRNA secondary structures in order to miscode a UGA stop codon and incorporate a 
Sec-tRNA instead190,191. Another rare amino acid pyrrolysine described only in bacteria 
and archaea is encoded by the stop codon UAG192. Regulation of gene expression of Sec 
containing proteins has been linked to human disorders including cancer. 
Diseases of ribosomal malfunction: Ribosomopathies 
Since ribosomes and translation are vital for survival, until recently it was 
believed that defects in ribosome biogenesis factors or translation machinery would either 
lack successful biogenesis or protein synthesis or have a translation apparatus not fit for 
survival. However, in last few decades very specific diseases of ribosome biogenesis 




Although these diseases encompass deficiencies in very fundamental and ubiquitous 
processes, their clinical manifestations are varied and tissue specific. Most of these 
diseases are congenital, and they share several common features like small stature, 
defects in early developmental pathways, cancer predisposition and hematological 
disorders.  
Diseases of SSU biogenesis 
Mutations in the gene encoding Treacle (TCOF1) cause an autosomal dominant 
craniofacial disorder called Treacher Collins Syndrome. Treacle is a putative nucleolar 
phosphoprotein that plays a role in rDNA transcription and methylation of 18S rRNA193. 
The disease appears to be due to happlosufficiency of Treacle than due to dominant 
negative effects in heterozygous patients with TCOF1 mutations in one allele194. Male 
infertility is caused by mutations in the gene encoding UTP14, an essential SSU 
processosome protein required for 18SrRNA maturation. The disease develops due to 
happloinsufficiency of protein UTP14c expressed by one of the variants of UTP14 genes 
UTP14c, an active retroposon expressed only in the testes and ovaries195. Cirhin/UTP4 is 
a member of a sub-complex of SSU processosome required for optimal transcription of 
rDNA in both yeast and humans. A missense mutation in the C-terminus of Cirhin causes 
North American Indian childhood cirrhosis, an autosomal recessive disorder  in a specific 
human population196. Bowen-Conardi syndrome (BCS) is a lethal autosomal recessive 
disorder observed primarily in Hutterite population. The associated symptoms are growth 




a missense mutation in the gene coding EMG1, a putative methyltransferase required for 
40S biogenesis197.  
Diseases of LSU biogenesis 
Alopecia, neurological defects, and endocrinopathy syndrome (ANE syndrome) is 
a clinically heterogeneous autosomal recessive disease caused my mutation in RBM28 
protein coding gene. RBM28 is important for 60S biogenesis. Shwachman-Bodian-
Diamond syndrome (SDS) is a pleiotropic autosomal recessive disorder, manifesting 
several hypoproliferative symptoms such as short stature, neutropenia, hematologic 
disorders, anemia and predisposition to leukemia. 90% cases of SDS are reported to be 
caused by mutations in gene coding SBDS, a protein involved in maturation and export 
of 60S subunit47,198.  
Some mutations in ribosome biogenesis factors act as modifiers of pre-existing 
conditions. E.g., mutations in gene encoding WDR36, a member of a sub-complex of 
SSU processosome causes a more severe form of disease in patients with Primary open 
angle glaucoma (POAG), the leading cause of blindness.  
Diseases of snoRNP malfunction 
RNase MRP is a ribonucleoprotein involved in ribosome biogenesis. It is an 
endonuclease which cleaves the pre-rRNA and separates precursors for SSU and LSU 
rRNA processing. Mutations in genes for the non-coding RNA component of RNase 
MRP are genetically linked to skeletal dysplasias which can be clinically classified from 




anemia, immunodeficiency and increased predisposition to cancer. Dyskeratosis 
congenital (DC) is a genetic disease caused by mutations in the components of Box 
H/ACA snoRNPs responsible for the pseudouridylation modification of rRNA It is 
characterized by genetic as well as symptomatic heterogeneity which include 
mucocutaneous abnormalities, predisposition to variety of cancers, bone marrow failure, 
immunodeficiency, growth retardation and neurological symptoms. DC iis an X-linked 
recessive or autosomal dominant disorder caused by mutations in the dyskerin gene, 
encoding an essential component of Box H/ACA snoRNPs. Prader-Willi Syndrome is a 
complex disease caused by silencing of genes encoding components of Box C/D 
snoRNPs and characterized by neonatal hypotonia, short stature, hyperphagia and obesity 
and hypogonadism. Box C/D snoRNPs typically catalyze 2’-o-ribose methylation of 
rRNA199. 
Diseases of ribosomal proteins 
Happloinsufficiency of some r-proteins leads to diseases of the bone marrow such 
as Diamond Blackfan anemia (DBA). DBA is an inherited bone marrow failure syndrome 
of children characterized by proapoptotic hematopoiesis, bone marrow failure, birth 
defects and predisposition to cancer. In some cases the disease also presents with 
craniofacial, cardiac, limb and urogenital abnormalities. All genes currently shown to be 
involved in DBA are r-protein genes200,201. Happloinsufficiency of these proteins 
resulting from mutation in their genes is likely to be the basis for DBA. Different types f 
mutation sin genes corresponding to proteins RPL19, RPL5, RPL11, RPL35A, RPL36, 




defects in ribosome biogenesis contributing to DBA. The r-proteins involved in DBA can 
also have other functions that could contribute to the development of the disease or the 
observed predisposition to cancer. Interactions of L19 with oncoproteins like PIM-1, 
modulation of activities of tumor suppressor p53, c-MYC, an oncoprotein and a 
transcription factor by RPL11, ability of RPS7, RPL5 and RPL23 to modify p53 activity 
indicates that mutations in r-protein genes can have a role in onset or progression of 
cancer in DBA patients. 5q- syndrome is characterized by defect in erythroid 
differentiation and associated with progression to acute myeloid leukemia. RPS14  is the 
happloinsufficient tumor suppressor gene associated with the syndrome202.  
Cancer onset in ribosomopathies 
The link between ribosomes and cancer is complex and not very well understood 
yet. To meet the requirements of cancer cells, ribosome biogenesis and nuclear structure 
are altered significantly; protein synthesis and transcription rates are increased. 
Dysregulation of ribosome biogenesis leads to inefficient ribosome production and hypo-
proliferative disorders. However, most ribosomopathies show predisposition to cancer, a 
hyper-proliferative phenomenon. Changes in mRNA translation control distinct cellular 
processes including metabolism, cell migration, cell adhesion, cell growth cell cycle 
control and tumorigenesis. R-proteins (RPL11 known) interact with c-MYC, p53 and 
MDM2 in order to regulate their oncogenic or tumor suppressor activities203,204. Thus 
happloinsufficiency of r-proteins leads to loss of regulation by them and increased 




Cancer in translation goes further from ribosome biogenesis to translation. Genes 
coding translation factors are aberrantly expressed during cancer progression. Translation 
initiation is the most regulated of the steps in translation and hence the several 
checkpoints coordinated by translation factors to control the levels of translation present 
as opportunities for oncogenic insult.  
 
 
Figure 24 Deregulation of translation control contributes to each step of cellular 





Scope of the current study 
The understanding of ribosome structure and mechanism of protein synthesis has 
come a long way since the earliest mid-century knowledge about the mysterious “small 
particles”. Atomic resolution crystal structures of ribosomes have created an explosion of 
knowledge about translation machinery. However, the tiny details of ribosome’s inside 
mechanisms are yet to be revealed. Some of the issues that need to be addressed include: 
a) How does the ribosome co-ordinate its rotational motion? b) How do the functional 
centers on a large macromolecule like ribosome communicate with each other? c) How 
does the ribosome maintain unidirectionality of translation d) how does it acquire a sort 
of “temporal specificity” for its ligands, and what changes in translation mechanism 
when the ribosomes go bad.  
The ribosome is a macromolecular conglomerate composed of many 
independently synthesized rRNAs and proteins. Studies of individual ribosomal 
components are essential for addressing the abovementioned issues. Some of the 
molecular pathways followed by these components are general while others are 
specialized. Ribosomal proteins were considered to be belonging to such a class of 
proteins involved mostly in rote like functions and cellular housekeeping. However, 
recent evidence has suggested more unique regulatory functions for ribosomes in specific 




Ribosomal Protein uL2 
Ribosomal protein L2 is an essential core ribosomal component that joins the 
ribosomal assembly process very early in the ribosome biogenesis pathway. It contacts 
the helices in the domains IV, V and VI and the PTC of the 25S rRNA.  This region of 
the rRNA is transcribed last and hence uL2 is one of the last r-proteins to be incorporated 
in early assembly around the time when the 7S pre-RNA is processed. uL2 (L2 in 
bacteria) is highly conserved in all three kingdoms and absolutely required for the 
peptidyltransferase activity of the ribosome.  
50S subunit alone is able to catalyze peptide bond formation207. uL2 was 
identified by photocrosslinking studies employing photoreactive groups attached to the 
CCA-end of A-, P-, and E-site-bound tRNAs,  as one of the crosslinked molecules that 
must be a part of or in close proximity to the catalytic center208 Photoaffinity labelling 
studies with peptidyltransfer inhibiting ribosomes have places bacterial L2, L15, L16, 
L18,L22, L23 and L27 at or near the PTC209. Studies involving photolabile 
oligonucleotides complementary to the PTC rRNA have also placed bacterial L2 and L3 
in the PTC vicinity210. 
Single protein omission studies showed that the proteins L2, L3, aL4 and 23S 
rRNA are essential, while other proteins as well as 5S rRNA are dispensable for 
catalyzing the peptidyl transfer211–213. Out of the eight to 10 proteins that were shown to 
be stably interacting with 23S rRNA, withstanding treatment with proteases, SDS and 
phenol214, the prime candidates for peptidyl-transferase activity then were L2, L3, L4 and 




was the most conserved protein in the large subunit215. 50S reconstitution studies showed 
that a highly conserves His 229 in E.coli L2 was essential for peptidyltransferase activity. 
Mutantion H229Q in L2 renders the E.coli ribosomes devoid of peptidyltransferase 
activity216. H229 was shown to be important for translational activity of ribosomes in in 
vivo studies also217. 
Peptide bond formation was described to be catalyzed by naked mature or in vitro 
transcribed 23S rRNA218,219, but this observation could not be reproduced220. Thus there 
remained a possibiliuty of ribosomal proteins, particularly L2 playing a central role in 
peptidyl transfer. The catalytic core of serine proteases has been proposed as a molecular 
model for the peptidyltransferase center. The ribosomal protein L2 contains the 
universally conserved seryl, histidyl, and aspartyl residues characteristic of the catalytic 
core of serine proteases and thus remained the center of interest in ribosomal peptide 
bond formation216. 
 Structurally, uL2 in yeast is a bilobular protein (Fig. 25A). It has a solvent 
accessible SH3 -barrel globular domain that participates in the intersubunit B7b bridge 
formation. The other lobe is composed of highly basic extensions that bury deep into the 
LSU core similar to proteins uL3, uL16 and uL4, approaching the PTC very closely (Fig. 
25B). The two lobes of L2 are connected by a neck region of the protein that is sheathed 





Figure 25 A. Structural features of yeast ribosomal protein uL2. B. Ribosomal 
Proteins with basic extensions approach the peptidyltransferase center very closely. 
A. uL2 is a bilobular protein that interacts with functionally important regions of the 
ribosome. It harbors an acidic globular domain which interacts with small subunit to form 
the B7b Bridge while the basic extension interacts with Helix 93 of LSU, approaching the 
peptidyltransferase center very closely. The two lobes of uL2 are connected by a neck 
region. B. A view of the active PTC with most of the RNA removed. Protein uL2, uL3, 
uL4 and uL16 have the closest extensions to the PTC and the peptide exit tunnel. Figure 
prepared using 3Å crystal structure of eukaryotic ribosome23.  
In the work presented ahead, mutants of uL2 in the intersubunit bridge forming 
region of uL2 were generated. Through a battery of genetic, functional and biochemical 
analyses, these mutants are characterized as responsible for causing defects in ribosomal 
function, mainly translational fidelity. Structure probing analysis reveals that these 
mutants perturb the rotational equilibrium of the ribosomes by interfering with its 
intersubunit-bridge forming ability and the dynamics of their transient existence. Such a 
disturbance in the natural ribosomal dynamics interferes with its ability to function as a 
highly sophisticated nanomachine. In higher eukaryotes where protein synthesis is more 
complex and translation profiles vary from one tissue type to other, an understanding of 
the mechanism of how r-protein mutations affect ribosome function can help in 




Chapter 2: Coordination of Ribosomal Rotation through Bridge 
B7b 
Introduction 
Successful conversion of genetic information from mRNA to proteins requires 
efficient and accurate functioning of the highly orchestrated nanomachine called the 
ribosome, a complex ribonucleoprotein particle universally composed of two subunits. 
Yeast ribosomes contain approximately 80 proteins and 4 rRNA molecules 221,222. Its high 
level of structural complexity confers the flexibility and versatility required to interact 
with a wide range of trans-acting ligands223,224. These include aminoacyl-tRNA 
containing ternary complexes (TC), the eEF2 translocase, and a host of release and 
recycling factors. Unidirectionality of translation is achieved by rotational motion of the 
two subunits relative to each other, and is energetically supported by several GTP 
hydrolysis reactions223–227. The two extreme stages of ribosomal rotation are called 
unrotated and rotated states228,229. It appears that intersubunit rotation is also accompanied 
by intersubunit “rolling” motions in eukaryotes26. During the translation elongation cycle, 
some intersubunit bridges function as “pivot points” upon which intersubunit rotation is 
balanced, while others are transient, breaking and re-forming as the subunits move 
between the two states. The B3 intersubunit bridge is an example of a pivot, while the 
B7a bridge exemplifies a rotational state dependent interaction130,230. Eukaryote 
ribosomes contain more intersubunit bridges than eubacterial or archaeal ribosomes, most 




freely rotate among as many as 40 – 50 conformations130,231.  Previous studies have 
suggested that disturbing this rotational equilibrium perturbs allosteric communication 
pathways within the ribosome. These in turn affect the steady-state affinities for trans-
acting factors, which manifest themselves as changes in translational fidelity232. 
Programmed alterations in translational fidelity have recently been shown to be 
responsible for regulating the expression of specific genes in from yeast to 
humans162,163,233, and global changes in translational fidelity, in particular in programmed 
-1 ribosomal frameshifting, have been linked to at least three human diseases234–236. 
. A correlation has been noted between defects in peripheral/late assembling 
ribosome proteins and a class of human diseases collectively known as 
ribosomopathies236. uL16 is assembled at the end of the LSU maturation process, is 
located on the periphery of the LSU, and directly interacts with the elongation factors 37 
To address the question of whether the connection between rotational equilibrium and 
translational fidelity is specific  to this class of ribosomal proteins or if it is a more 
generalized phenomenon, we tested it using mutants of the universally conserved core 
ribosomal protein uL2 (universal L2, previously known as L2)237. uL2 is incorporated 
into ribosomes in the early stages of biogenesis238. Structurally, uL2 contains a solvent-
accessible globular domain. This is linked to a second domain that closely that interfaces 
with the small subunit (SSU) through intersubunit bridge B7b (Fig. 26A). approaches the 
peptidyltransferase center through a functionally important “neck”.  uL2 is an integral 
protein that interacts with nearly every domain of the large subunit (LSU) rRNA11,23. 
Along with uL3, uL2 is required to maintain the peptidyltransferase center, and indeed, 




extension domain might directly participate in the peptidyltransferase reaction238. 
Mutants of uL2 have been characterized in both yeast and E. coli demonstrating 
conserved roles in subunit association and in ribosome structure, biochemistry, and 
translational fidelity239,240. In the current study, mutants of uL2 located in the SSU 
interface region were used to test the model of the importance of maintaining intersubunit 
rotational equilibrium on ribosome function. Consistent with prior studies of uL16, 
mutations of uL2 that drive the equilibrium towards the rotated state,  promote allosteric 
changes in functional centers of both subunits that favor binding of eEF2 and disfavor 
that of TC.  These in turn manifest as specific alterations in translational fidelity, which 
are biologically manifested, in part, by decreased telomere length.  A model describing 
how this perturbation of ribosome structural equilibrium alters specific aspects of 
translational fidelity is presented.  
Results 
Genetic characterization of uL2 mutants in the vicinity of B7b Bridge. 
Ribosomal protein uL2 is roughly bilobular.  One domain approaches the P-site of the 
peptidyltransferase center (Fig. 26B) and the other interacts with the small subunit 
through the B7b intersubunit bridge (Fig. 26A, Fig. 27). The results of a prior random 
mutagenesis study suggested that structural flexibility between the two domains may help 
to coordinate tRNA-ribosome interactions239.  Subsequently, studies of ribosomal protein 
uL16 suggested that changes in the equilibrium between intersubunit rotational states 
underlie biochemical, translational fidelity and gene expression defects236.  The current 





Figure 26 Location of L2 within the yeast ribosome ribosome:  
A. View of the ribosome from the E-site. 18S and 25S rRNA is shown in grey, 5S and 
5.8S rRNA in cyan. L2 is shown in blue, peptidyltransferase center in red and decoding 
center in green. L2 makes the intersubunit Bridge B7b interacting with helices h23 and 
h24 (shown in red) of SSU. B. Crown view of the large subunit shows strategic 
localization of ribosomal proteins near the peptidyltransferase center. Finger like basic 
insertion of L2 closely approaches the peptidyltransferase center (PTC) while the acidic 
























Figure 27 List of mutants of L2 ORF generated in this study and their location on 
uL2.  
Color codes are used to highlight the general regions mutagenized in uL2.Ribosomal 
structures generated in PyMol using 3Å resolution yeast ribosomal structures 
Using atomic resolution yeast ribosome structures as a guide23, six different 
regions of uL2 were identified as potentially interacting with the SSU. These are color 
coded in figure 27.  Initially, stretches of up to 5 amino acids in each region were mutated 
to alanine.  With one exception, none of these were viable as the sole form of uL2 (Fig. 
27).  Subsequently, mutants were made containing one, two or three alanine substitutions 
and were scored for viability. Dilution spot assays were employed to score the growth 
































The double stranded RNA L-A yeast killer virus maintains a toxin-encoding M1 
satellite. This toxin is responsible for the killer phenotype of the K+ strains. Cells that can 
maintain this virus create a zone of growth inhibition when spotted on a lawn of killer 
sensitive (uninfected) strain. For maintaining a precise ratio between the structural (Gag) 
and enzymatic (Gag-pol) products of translation, L-A utilizes Programmed -1 
frameshifting event (reviewed in Dinman, 1995). This ratio between the structural and 
enzymatic product is critical for the maintenance of M1 satellite (Dinman and Wickner, 
1992). Unhealthy ribosomes and defective mechanism of translation can impair this 
critical ratio L-A translational products necessary for M1 maintenance. The maintenance 
and propagation of the L-A virus is also affected by defects in large subunit biogenesis. 
Thus the yeast killer assay provides a quick and easy method for directly screening 
defects in the translation machinery of yeast cells. 
“Killer” assays were employed to score the ability of these mutants to maintain 
the yeast killer virus (Fig. 29B). Drug sensitivity was evaluated by growing cells in liquid 
culture containing either 25µg/ml Anisomycin or 30µg/ml Sparsomycin (Fig. 30A and 
B). These drugs are inhibitors of translation: anisomycin competes with the CCA-end of 
A-site tRNA in binding to the A-site in LSU while Sparsomycin binds to the P-site and 
interferes with peptidyl tRNA binding and peptidyl transferase reaction. All mutants were 
assayed with regard to their quantitative effects on four aspects of translational fidelity: -
1 PRF, +1 PRF, UAA termination codon readthrough, and suppression of a near cognate 




phenotypes were selected for further characterization:  H139-E143A, uL2-K177A, 
deletion of the C-terminal end (248 – 254∆), and uL2-Y133A. 
 
Figure 28 Multiple sequence alignment of uL2 amino acid from different species. 
Multiple Sequence Alignment shows that uL2 is a universally highly conserved protein. 
The regions of the protein that were mutagenized are highlighted in appropriate colors 
matching to the regions shown in figure 27. 
  
H.sapiens           -----------------------------MGRVIRGQRKGAG-SVFRAHVKHRKGAARLR 30 
M.musculus          -----------------------------MGRVIRGQRKGAG-SVFRAHVKHRKGAARLR 30 
D.melanogaster      -----------------------------MGRVIRAQRKGAG-SVFKAHVKKRKGAAKLR 30 
S.cerevisiae        -----------------------------MGRVIRNQRKGAG-SIFTSHTRLRQGAAKLR 30 
H.marismortui       -----------------------------MGRRIQGQRRGRGTSTFRAPSHRYKADLEHR 31 
E.coli              MAVVKCKPTSPGRRHVVKVVNPELHKGKPFAPLLEKNSKSGGRNNNGRITTRHIGGGHKQ 60 
T.thermophilus      MAVKKFKPYTPSRRFMTVADFSEITKTEPEKSLVKPLKKTGGRNNQGRITVRFRGGGHKR 60 
                                                     :.   :  * .          .  . : 
 
H.sapiens           AVDFAERHG----YIKGIVKDIIHDPGRGAPLAKVVFRDPYRFKKRTELFIAAEGIHTGQ 86 
M.musculus          AVDFAERHG----YIKGIVKDIIHDPGRGAPLAKVVFRDPYRFKKRTELFIAAEGIHTGQ 86 
D.melanogaster      SLDFAERSG----YIRGVVKDIIHDPGRGAPLAVVHFRDPYRYKIRKELFIAPEGMHTGQ 86 
S.cerevisiae        TLDYAERHG----YIRGIVKQIVHDSGRGAPLAKVVFRDPYKYRLREEIFIANEGVHTGQ 86 
H.marismortui       KVEDGD-------VIAGTVVDIEHDPARSAPVAAVEFEDGDR-----RLILAPEGVGVGD 79 
E.coli              AYRIVDFKR-NKDGIPAVVERLEYDPNRSANIALVLYKDGER-----RYILAPKGLKAGD 114 
T.thermophilus      LYRIIDFKRWDKVGVPAKVAAIEYDPNRSARIALLHYVDGEK-----RYIIAPDGLQVGQ 115 
                         :        : . *  : :*. *.* :* : : *  :     . ::* .*: .*: 
 
H.sapiens           FVYCGKKAQLNIGNVLPVGTMPEGTIVCCLEEKPGDRGKLARASGNYATVISHNPETKKT 146 
M.musculus          FVYCGKKAQLNIGNVLPVGTMPEGTIVCCLEEKPGDRGKLARASGNYATVISHNPETKKT 146 
D.melanogaster      FVYCGRKATLQIGNVMPLSQMPEGTIICNLEEKTGDRGRLARTSGNYATVIAHNQDTKKT 146 
S.cerevisiae        FIYAGKKASLNVGNVLPLGSVPEGTIVSNVEEKPGDRGALARASGNYVIIIGHNPDENKT 146 
H.marismortui       ELQVGVDAEIAPGNTLPLAEIPEGVPVCNVESSPGDGGKFARASGVNAQLLTH--DRNVA 137 
E.coli              QIQSGVDAAIKPGNTLPMRNIPVGSTVHNVEMKPGKGGQLARSAGTYVQIVAR--DGAYV 172 
T.thermophilus      QVVAGPDAPVQVGNALPLRFIPVGTVVHAVELEPKKGAKLARAAGTSAQIQGR--EGDYV 173 
                     :  * .* :  **.:*:  :* *  :  :* .. . . :**::*  . :  :  :   . 
 
H.sapiens           RVKLPSGSKKVISSANRAVVGVVAGGGRIDKPILKAGRAYHKYKAKRNCWPRVRGVAMNP 206 
M.musculus          RVKLPSGSKKVISSANRAVVGVVAGGGRIDKPILKAGRAYHKYKAKRNCWPRVRGVAMNP 206 
D.melanogaster      RVKLPSGAKKVVPSANRAMVGIVAGGGRIDKPILKAGRAYHKYKVKRNSWPKVRGVAMNP 206 
S.cerevisiae        RVRLPSGAKKVISSDARGVIGVIAGGGRVDKPLLKAGRAFHKYRLKRNSWPKTRGVAMNP 206 
H.marismortui       VVKLPSGEMKRLDPQCRATIGVVGGGGRTDKPFVKAGNKHHKMKARGTKWPNVRGVAMNA 197 
E.coli              TLRLRSGEMRKVEADCRATLGEVGNAEHMLRVLGKAGAARWRGVR-----PTVRGTAMNP 227 
T.thermophilus      VLRLPSGELRKVHGECYATVGAVGNADHKNIVLGKAGRSRWLGRR-----PHVRGAAMNP 228 
                     ::* **  : :     . :* :... :    : ***             * .**.***. 
 
H.sapiens           VEHPFGGGNHQH-IGKPSTIRRDAPAGRKVGLIAARRTGRLRGTKTVQEKEN 257 
M.musculus          VEHPFGGGNHQH-IGKPSTIRRDAPAGRKVGLIAARRTGRLRGTKTVQEKEN 257 
D.melanogaster      VEHPHGGGNHQH-IGKASTVKRGTSAGRKVGLIAARRTGRIRGGKGDSKDK- 256 
S.cerevisiae        VDHPHGGGNHQH-IGKASTISRGAVSGQKAGLIAARRTGLLRGSQKTQD--- 254 
H.marismortui       VDHPFGGGGRQH-PGKPKSISRNAPPGRKVGDIASKRTG--RGGNE------ 240 
E.coli              VDHPHGGGEGRN-FGKHPVTPWGVQTKGKKTRSNKR-TDKFIVRRRSK---- 273 
T.thermophilus      VDHPHGGGEGRAPRGRPPASPWGWQTKGLKTRKRRKPSSRFIIARRKK---- 276 






Figure 29 rpL2A bridge mutants promote various phenotypic defects.  
(A) Ten-fold serial dilutions of cultures of indicated S.cerevisiae strains were spotted on 
rich medium and incubated for 48 hours at 30°C, 15°C, and 37°C to score for growth, 
cold and heat sensitivity respectively. (B) “Killer” virus phenotypes: The Killer+ 
phenotype is scored by the presence of a halo of growth inhibition around wild-type 
colony. Lack of the halo around colonies expressing the H139-E143A and K177A L2 





Figure 30 Drug sensitivity assays.  
Growth curves were generated in quadruplicate with a Synergy HT micro-plate reader 
utilizing the KC4 software package (Bio-Tek Instruments, Inc., Winooski, VT). Yeast 
growth at 30°C was measured in 96-well plates beginning with 0.1 ml cultures of cells in 
YPAD medium diluted to OD595=0.05.Cultures were subjected to constant high-intensity 
shaking and automatic OD595 readings were taken of each well at 10-min intervals for 
48h. Duplicate cultures were independently assayed twice and the four readings were 












































































































































Figure 31 uL2 mutants promote defects in translational fidelity.  
Isogenic yeast cells expressing either wild-type or mutant forms of uL2 were transformed 
with dual luciferase reporters and control plasmids and rates of translational recoding 
were determined. All results are graphed as fold wild type. −1 PRF was measured using 
the yeast L-A virus frameshift signal. +1 PRF was directed by the frameshift signal 
derived from the Ty1 retrotransposable element. Rates of termination codon readthrough 
were measured using a reporter harboring an in-frame UAA termination codon positioned 
between the Renilla and firefly luciferase reporter genes. Rates of suppression of 
missense suppression near- and non-cognate codons were evaluated by incorporation of 
an arginine (AGA) instead of a cognate serine (AGC) at the firefly luciferase catalytic 





uL2 mutants in the B7b intersubunit bridge region disrupt the rotational equilibrium 
of ribosomes 
A comprehensive analysis using hSHAPE defined the chemical reactivity profiles 
of non-rotated and rotated yeast ribosomes232. This study established that the reactivity of 
the two bases in the B7a intersubunit bridge, G913 to kethoxal and A2207 to 1M7, can be 
used as diagnostic markers of intersubunit rotational status.  The involvement of these 
two bases in a base triple interaction in the unrotated state render them resistant to 
chemical modification, while disruption of this interaction in the rotated state allows 
them to react (Fig. 32A).  The extent of base chemical modification was measured in bulk 
equilibrium using isogenic wild-type and mutant ribosomes.  The reactivity of these two 
bases in wild-type ribosomes was used to set the baseline for rotational equilibrium at 
steady state. Thus, increases or decreases in base modification are indicative of shifts in 
equilibrium, rotated or unrotated respectively.  Chemical modification analyses revealed 
increased extents of chemical modification for all four mutants (Fig. 32B), indicating 
shifts in equilibrium toward the rotated state. The most pronounced shifts were observed 
for the uL2-K177A and uL2-Y133A mutants. More extensive hSHAPE analyses revealed 
that the uL2-K177A and uL2-Y133A promoted similar changes in 1M7 base 
modifications in both the SSU and LSU (Fig. 33, 34, and 37).  In the SSU (Fig. 33and 
Fig. 37), these mutants tend to render bases in h23 more susceptible to chemical 
modification, i.e. more flexible.  Conversely the two mutants made bases in h23a, h24 
and h27 became less prone to modification, i.e. less flexible. In the LSU (Fig. 34 and Fig. 





Figure 32 uL2 B7b bridge mutants alter the rotational equilibrium of the ribosome.  
(A) The B7a intersubunit bridge. In the non-rotated ribosome, A2207 (25S rRNA) and 
G913 (18S rRNA) engage in a triple base interaction along with G2206. In the rotated 
state, the base triple is disrupted, and the 2’ OH-group on A2207 becomes accessible to 
modification by 1M7.  Similarly, atoms on G913 become accessible to modification by 
kethoxal upon rotation. Images were generated in pymol using atomic resolution yeast 
ribosomal structures 23,241. E. coli base numbers are shown in parentheses. (B) Reactivity 
peaks obtained by hSHAPE after chemical probing of the landmark base G913 (arrows) 
at the SSU side of the B7a intersubunit bridge with kethoxal (upper panel) and probing of 
the landmark base A2207 (arrows) at the LSU side of the B7a intersubunit bridge with 
1M7 (lower panel). Shown here are the capillary electrophoresis traces from primer 
extension reactions of IM7 reacted rRNA after sequence alignment and correcting for the 





















Figure 33 Structural probing analysis of 18S rRNA of Wild-type and uL2-K177A.  
Chemical probing analysis using 1M7 and hSHAPE was performed as described in 
Leshin et al.242, Reactivity difference between L2-K177A and WT for the bases covered 
was mapped on the 2d map of 18S rRNA. The scale at right indicates the extent of 
differences in reactivity with each number corresponding to one standard deviation from 





Figure 34 Structural probing analysis of 25S rRNA of Wild-type and uL2-K177A.  
Chemical probing analysis using 1M7 and hSHAPE was performed as described in 
Leshin et al.242, Reactivity difference between L2-K177A and WT for the bases covered 
was mapped on the 2d map of 25S rRNA. The scale at right indicates the extent of 
differences in reactivities with each number corresponding to one standard deviation 





Figure 35  Magnified view of the Structure probing in SSU. 
Reactivity difference between L2-K177A and WT for A. h24, B. h23 and h23a, C. h27, 





Figure 36 Magnified view of the Structure probing in SSU. 
Reactivity difference between L2-K177A and WT for A. H90, 91, 92, and H95 B. H69, 




in the peptidyltransferase center (also see Fig. 37), Helices 89 – 92 (the tRNA 
accommodation corridor), and H69 which interrogates the decoding center during 
translation elongation. 
 
Figure 37 Three dimensional representation of 1M7 reactivity difference.  
Differences in IM7 reactivity between uL2-K177A and WT 18S and 25S rRNA regions 
were probed by hSHAPE. The reactivity differences were assigned colors codes 
according to the scale shown to the right. Warmer colors indicate increased reactivity and 
cooler colors denote decreased reactivity.  Scored data were mapped on 3.0 Å resolution 




















Figure 38. Comparison of SHAPE reactivity of individual ribosomal bases to non-
rotated and rotatated control ribosomes. 
Salt washed empty uL2-WT and uL2-K177A were chemically probed with 1M7 and 
analyzed by hSHAPE.  Reactivity values for non-rotated and rotated controls were 
obtained from Sulima et al232. Non-rotated control yeast ribosomes were primed with 
polyU and contained Ac-Phe-tRNAPhe in the P-site.  Rotated control ribosomes were 
primed with polyU, loaded with deacylated Phe-tRNA, and incubated with eEF-2-
GDPNP. Reactivity for bases involves in bridge B7a, B2a, B3, Accommodation Corridor 
(AC), Helix 93 (H93), AND Sarcin-Ricin loop are shown here. 
Some mutants of uL2 in the B7b region cause defects in ribosome biogenesis pathway 
and subunit joining defects in elongation pathway. 
Sucrose density gradient analyses of polysomes demonstrated that, most of the 
uL2 mutants generated in this study had defects mild to severe ribosome biogenesis 
defects. In figure 39, the first two peaks in polysome profiles correspond to the 40S and 
60S subunits. In WT ribosomes the 40S:60S UV absorbance ratio is about 1.  
Region rRNA base Non-rotated WT K177A Rotated 
B7a A2207 2 0 2 4 
B2a U2258 2 3 4 4 
  C1644 (SSU) 1 1 2 2 
  G1645 (SSU) 0 1 1 1 
B3 U2301 0 0 0 1 
  G2302 0 0 0 0 
  A1655 (SSU) 1 1 2 2 
  U1656 (SSU) 2 2 2 2 
AC U2860 1 0 1 0 
  U2924 4 3 3 1 
  A2926 4 3 2 1 
H93 A2971 4 4 1 1 
SRL U3023 1 0 0 0 





Figure 39 Polysome profiles of cells expressing WT and mutant uL2. 
Polysome profiles were generated by Sucrose density gradient fractionation of 
cycloheximide arrested cell lysates of WT and mutant rpL2A expressing strains of yeast. 
The first two peaks stand for 40S and 60S subunits respectively, the third peak is 80S 
ribosome and the subsequent peaks represent two or more ribosomes present on the same 
mRNA. In WT cells, the ratio 40S:60S s about 1, while in mutants the 60S is peak is 
significantly lowered due to ribosome biogenesis defects. Shoulders to regular peaks are 
called half-mers and they represent subunit joining defects in translation or lack of 




In mutants uL2-248-254 and uL2-Y133A, these ratios are slightly raised, cells 
expressing uL2-H139-E143A or uL2-K177A display severe defects in 60S biogenesis. 
The ribosomes that survive the surveillance in ribosome biogenesis are exported to the 
cytoplasm and can participate in translation there. The presence of shoulders to the 
regular peaks (helf-mers) in polysome profiles demonstrate mutants uL2-H139-E143A 
and uL2-K177A display subunit joining defects; where 60S subunit fails to join the 
initiation complex for translation to proceed either due to lack of adequate free 60S 
subunits or because of reduced intermolecular interactions resulting from the mutations. 
Disruption of ribosome rotational equilibrium by uL2 mutants affects binding of 
translation elongation factors. 
Structural analyses of the translation elongation cycle suggested that ribosome 
rotational status determines the affinity of the two elongation factors with the A-site 
ribosome; the TC that delivers amionacylated tRNAs and the translocase244.  In yeast 
ribosomes, this model was supported using mutants of uL16, i.e. unrotated ribosomes had 
higher affinity for TC (eEF1A•aminoacyl-tRNA•GTP) and rotated ribosomes had higher 
affinity for translocase (eEF2•GTP)232. To test the universality of this model, steady-state 
filter binding assays were performed using the uL2 mutants identified in the current 
study. Ribosomes containing the two must rotated mutants, uL2-K177A and uL2-Y133A 
displayed more than two-fold increases in KD for TC (P<0.01), and conversely, nearly 2-
fold decreases in KD for eEF2•GDPNP (P<0.06) (Fig. 40A, 40B, Fig. 41A – 41D).  uL2-
248-254∆ mutant ribosomes, which promoted a lesser extent of shift in equilibrium 




H139-E143A, having the least pronounced effect on rotational equilibrium, did not 
significantly affect TC binding. The uL2-K177A and C-terminal deletion mutants also 
conferred decreased affinity for N-acetyl-aminoacyl-tRNA (Ac-aa-tRNA) to the P-site, 
while the uL2-H139-E143A mutant promoted a small but significant increase in this 
parameter (Fig 40C, 41E, F).  
 
Figure 40 uL2 B7b bridge mutants of alter the binding of translation elongation 
factors.  
Dissociation constants (Kd) were generated by analysis of single-site binding isotherms of 
[14C]Phe-tRNAPhe•eEF1A•GTP (ternary complex) (A), or of eEF2 to the ribosomal A-
site (B), and Ac-[14C]Phe-tRNAPhe to the P-site (C). Binding assays are explained in 













































































Figure 41 Biochemichal analyses of rpl2A  mutants.  
Single site binding isotherms of ternary complex to the A-site of ribosomes isolated from 
wild-type, rpl2- H139-E143A, rpl2-K177A, rpl2-G248-D254 and rpl2-Y133A cells 
(panel a). B. Ternary complex binding dissociation constants (Kds) calculated using 
ligand depletion model (Graphpad Prizm). C. Single site binding isotherms of eEF2 to 
ribosomes isolated from wild-type, rpl12-K177A, and rpl2-Y133A cells. D. eEF2 binding 
Kds calculated using ligand depletion model (Graphpad Prizm). E.  Single site binding 
isotherms N-Ac-Phe-tRNAPhe to the P-site of ribosomes isolated from wild-type, rpl2- 
H139-E143A, rpl2-K177A, rpl2-G248-D254 and rpl2-Y133A cells. F. N-Ac-Phe-
tRNAPhe binding Kds calculated using ligand depletion model (Graphpad Prizm). Error 
bars indicate standard error. (n=4, * P < 0.06, ** P<.001) 


















































































































































Mutants of rpl2A encoding uL2-248-254 and uL2-K177A do not affect the rates of 
puromycyl-peptidyltransferase reaction, a proxy for peptidyltransfer reaction. 
Ribosomes purified from WT uL2 and uL2-248-254 or uL2-K177A expressing 
cells were purified as previously described. Complex C were formed by incubating N-
Ac-[14C]Phe-tRNAPhe , followed by glycerol ultracentrifugation to remove access tRNA. 
Apparent rates of peptidyltransfer from single turnover peptidylpuromycin reactions 
revealed that the mutants do not vary largely in their peptidyltaransferase activity from 
the wild type. There was a very mild decrease in uL-K177A activity while uL2-248-254 
displayed no significant difference from the WT. 
 
Figure 42  Single turnover peptidylpuromycin reactions. 
Extent on complex C conversion to peptidyl Puromycin is measured radioactively.  













































Figure 43 Translation fidelity assays for selected uL2 mutants.  
Isogenic yeast cells expressing either wild-type or mutant forms of uL2 were transformed 
with dual luciferase reporters and control plasmids and rates of translational recoding 
were determined. All results are graphed as fold wild type. −1 PRF was measured using 
the yeast L-A virus frameshift signal. +1 PRF was directed by the frameshift signal 
derived from the Ty1 retrotransposable element. Rates of termination codon readthrough 
were measured using a reporter harboring an in-frame UAA termination codon positioned 
between the Renilla and firefly luciferase reporter genes. Rates of suppression of 
missense suppression near- and non-cognate codons were evaluated by incorporation of 
an arginine (AGA) instead of a cognate serine (AGC) or a non-cognate serine (TCT) at 
the firefly luciferase catalytic codon 218. Error bars denote standard error. n=4-10 
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The uL2-K177A and uL2-Y133A mutants promote significant changes in 
translational fidelity.   
Dual luciferase based in vivo assays were used to monitor the effects of the two 
mutants on five different aspects of translational fidelity. In general, and consistent with 
the strongest effects on intersubunit rotation, the uL2-K177A mutant conferred the 
strongest changes in translational fidelity (Fig. 43).  Both mutants conferred increased 
rates of -1 PRF, consistent with studies indicating that rotated ribosomes are substrates 
for this reaction172,245. In contrast, uL2-K177A ribosomes promoted a >50% decrease in 
rates of +1 PRF, while uL2-Y133A mutants promoted a modest but statistically 
insignificant increase. uL2-K177A also led to a nearly 3-fold increase in readthrough of 
the UAA termination codon.  However, the most pronounced effects were observed in 
conjunction with the effects of this mutant on the ability of ribosomes to discriminate 
between cognate and either near-or non-cognate tRNAs, where greater than 30-fold 
increases in suppression of these classes of codons were observed for both mutants.  
The uL2-K177A mutant affects gene expression and telomere maintenance through 
changes in programmed ribosomal frameshifting.  
In yeast, the mRNAs encoding at least four proteins (EST1, EST2, STN1, 
CDC13) involved in telomere maintenance contain -1 PRF signals that function as 
destabilizing elements by directing translating ribosomes to premature termination 
codons182.  The EST3 mRNA encoding a fifth telomere maintenance protein harbors a +1 
PRF signal that is identical to the Ty1 recoding element that is required for synthesis of 




antizyme requires a +1 PRF event for its synthesis248. Dual luciferase reporters harboring 
these frameshift signals were assayed in isogenic wild-type and uL2-K177A cells (Fig. 
44A).  These assays revealed that -1 PRF directed by signals in the EST1, EST2, and 
STN1 mRNAs was stimulated in the mutant cells.  -1 PRF directed by the CDC13 
sequence only slightly stimulated by the uL2 mutation.  +1 PRF directed by the OAZ1 
sequence was also strongly inhibited in mutant cells (<25% of wild-type).   qRT-PCR 
assays revealed decreases in the steady state abundances of  all of the PRF signal 
containing mRNAs.   
 
Figure 44 uL2-K177A mutant ribosomes promote defects in cellular gene expression 
and telomere maintenance through altered frameshifting.  
 A. Rates of −1 PRF were determined by sequences derived from yeast EST1 (signal 
beginning at nucleotide 1,272), EST2 (signal beginning at nucleotide 1,326), STN1 
(signal beginning at nucleotide 1,203), and CDC13 (signal beginning at nucleotide 
1,272), and of +1 PRF directed by sequence in the OAZ1 mRNA. B. Steady-state 
abundance of endogenous EST1, EST2, STN1, CDC13, OAZ1 and EST3 mRNAs was 
monitored by quantitative RT-PCR. Bars indicate SEM. C. The abundance of telomere 
repeat sequences was quantified by PCR, with the single-copy reference gene SGS1 as 
the loading control. T/S ratios of calculated from Ct values represent relative telomere 















































































Decreased abundance of the -1 PRF signal containing mRNAs is consistent with 
findings that they function as mRNA destabilizing elements by directing translating 
ribosomes to premature termination codons 181,182.  Similarly, since +1 PRF events are 
required for synthesis of full-length Est3p and Oaz1p, decreased rates of +1 PRF is 
predicted to increase the fraction of ribosomes directed to premature termination codons 
on these mRNAs, also reducing their steady-state abundances. qRT-PCR assays revealed 
that the abundance of telomere DNA repeats (a proxy for telomere length) in uL2-K177A 
mutant cells was reduced approximately two-fold compared to isogenic wild-type cells 
(Fig. 44C). This is consistent with the idea that PRF plays an important role in yeast 
telomere maintenance. 
Discussion 
The ribosome transits through a large number of conformational states during the 
translation elongation cycle, the two extremes of which are called unrotated and 
rotated249.  The structural and biochemical analyses with the uL2 mutants (Figs. 32-37) 
demonstrate a direct relationship between ribosome rotational status and affinity for the 
two elongation factors. These observations broaden the support for the general model in 
which unrotated ribosomes have higher affinity for TC and lower affinity for the 
translocase, and these properties are reversed upon intersubunit rotation (Fig. 45A).  
The selection of appropriate ligands to the ribosomal A-site during translation 
elongation is governed by a delicate series of kinetically separated steps250,251. Disruption 
of these parameters by the uL2 mutants examined here is manifested at the level of rRNA 




demonstration of changes in rRNA structure in all of the functional centers located in 
both subunits is consistent with allosteric information exchange pathways identified using 
other mutants of yeast proteins and rRNA bases232,252–259.  Increased reactivity of bases in 
the B7a intersubunit bridge is diagnostic of the intersubunit rotational equilibrium having 
shifted toward the rotated state. This is further supported by the observed closing of the 
tRNA accommodation corridor (decreased reactivity in H89 – H92), stabilization of 
A2971 (E. coli 2602) in the peptidyltransferase center, and stabilization of h27. These 
observations lend further support to the model linking ribosome rotational status to 
elongation factor binding affinity.  Here, we present a model illustrating how these 
changes in structure and biochemistry account for the observed changes in translational 
fidelity (Fig. 45).  The substrate for Ty1 and EST3 directed +1 PRF is a ribosome paused 
at the CUU AGG C heptameric slippery site with a peptidyl-tRNA base paired to the P-
site CUU codon, and awaiting the rare cognate tRNA(CCUArg) at the A-site186, i.e. an 
unrotated ribosome (Fig. 45A).  In contrast, rotated ribosomes containing hybrid-state 
tRNAs have been demonstrated to be the substrates for -1 PRF164,172,173,245 (Fig. 45A). By 
shifting the rotational equilibrium towards the rotated state, these mutants increase the 
steady-state abundance of -1 PRF substrate, thus stimulating this process. In contrast, 
decreased abundance of the +1 PRF substrate results in decreased rates of +1 PRF. 
Similarly, since the release factors bind to unrotated ribosomes, decreasing this substrate 
inhibits this function, leading to increased rates of UAA termination codon readthrough, 
at least for the uL2-K177A mutant (i.e. the mutant that most disrupted rotational 
equilibrium).  The most dramatic changes in translational fidelity were observed as 




cognate tRNAs.  As shown in Fig. 45B, the unrotated ribosomes are the substrate for TC 
binding. Elegant biochemical studies have detailed the kinetic parameters underlying the 
high fidelity selection of cognate tRNAs during the translation elongation process250,260.  
Importantly, these analyses have shown that rapid dissociation of near-cognate tRNAs 
from ribosomes is the first step of discrimination. Specifically, near cognate tRNAs 
dissociate at rates of ~80 sec-1 as compared to ~0.2 sec-1 for cognate tRNAs, a 400-fold 
difference.  However, shifting the population of ribosomes toward the rotated state 
increases the steady-state KD of ribosomes for all TCs.  We suggest that this 
disproportionately affects TCs harboring cognate tRNAs, reducing ability of ribosomes to 
discriminate between cognate and near-cognate TCs.  Alternatively, increased rate of 
misincorporation of tRNAs could be resulting from a higher rate of tRNA 
accommodation in mutant uL2 ribosomes. Increased propensity of these ribosomes to rest 
in rotated state could speed up the transition from unrotated to rotated state thus driving 
the accommodation of tRNAs at higher rates. 
Expression of up to 10% of cellular genes is predicted to be regulated by -1 
PRF261,262, and +1 PRF has been demonstrated in at least two additional yeast 
mRNAs263,264. -1 PRF events in yeast mRNAs encoding proteins critical for telomere 
maintenance direct translating ribosomes to premature termination codons, resulting in 
mRNA degradation through the nonsense-mediated mRNA decay pathway (NMD)181,233.  
Thus, increased rates of -1 PRF promoted by the uL2-K177A mutant promoted decreased 
abundances of the -1 PRF signal containing EST1, EST2, STN1 and CDC13 mRNAs. In 




Here, decreased rates of +1 PRF results in a greater fraction of ribosomes encountering 
the 0-frame termination codons in these mRNAs, decreasing their abundances 
presumably also through NMD.  At the biological level, the proteins encoded by EST 
family of genes, STN1 and CDC13 are all involved in yeast telomere maintenance265.  
The observed changes in -1 and +1 PRF resulted in decreased abundance of yeast 
telomere repeats, indicative of enhanced telomere shortening. While it is not known if 
mRNAs encoding proteins required for human telomere maintenance are regulated by 
PRF, should this be demonstrated in the future, the findings presented here may provide a 
link between PRF and the progeria-like presentations of some ribosomopathies266. OAZ1 
encodes ornithine decarboxylase antizyme, the critical control node in polyamine 
biosynthesis267. Disruption of this pathway has pleiotropic effects, including control of 
cellular proliferation and development183,268.  The recent demonstration of -1 PRF and 
termination codon readthrough regulated gene expression humans provide evidence for 
importance of translational recoding in fine-tuning the immune system and control of 
tumor progression162,163. The effects of the uL2 mutants on translational fidelity described 






Figure 45 Model describing the effects of disturbed ribosomal rotational 
equilibrium on tRNA selection and translational fidelity.  
(A) The uL2 B7b Bridge mutants perturb the dynamic rotational equilibrium of 
ribosomes by shifting it towards the rotated state.  This increases the steady-state 
abundance of -1PRF substrate (rotated ribosomes) while creating a deficit of +1 PRF 
substrate (unrotated ribosomes). (B) Kinetics of initial selection and ternary complex 
binding is affected by uL2 mutants. In wild type ribosomes, lower koff  rates for cognate 
ternary complex than the near-cognate normally ensures high fidelity of tRNA selection 
(~400-fold) 94. Shifting rotational equilibrium toward the rotated state disproportionately 
increases the koff for cognate ternary complex relative to near- or non-cognate (which are 






Chapter 3: Materials and Methods 
Strains, Plasmids and media in generation of rpl2A mutants  
S. cerevisiae strain JD1269 containing wild-type RPL2A on a centromeric URA3 
vector (pRPL2A-URA3) was previously described239. In JD1315, the wild type vector 
was replaced by wild type RPL2A on a centromeric LEU2 vector (pRPL2A-LEU2 or 
pJD957) through standard 5-FOA shuffling technique269. Mutations in the rpL2A ORF of 
pRPL2A-LEU2 were generated by site-directed mutagenesis technique. Site-directed 
mutagenesis was carried out using the Quikchange XL site-directed mutagenesis kit 
following the directions of the manufacturer (Stratagene, Madison, WI, USA). Plasmids 
were amplified in E. coli strain DH5. Mutant RPL2A strains were generated by 
replacing pRPL2A-URA3 with pRPL2Amut-LEU2 through standard 5-FOA plasmid 
shuffle technique. Escherichia coli were transformed using a calcium chloride method270 
and yeast cells were transformed with an alkali cation protocol271. YPAD, synthetic 
complete (SC), synthetic dropout medium (H-), and 4.7 MB plates for testing the killer 
phenotype were used as previously described272,273. The S. cerevisiae strains, and 
oligonucleotides (IDT, Coralville, IA, USA) used in this study are shown in appendices.  
Growth and Drug Sensitivity assays 
Dilution spot assays were used to qualitatively monitor cell growth at various 
temperatures and drug concentrations. For all conditions, yeast cells were grown to 
logarithmic growth phase and then diluted to 1X106 CFU/ml. Subsequently, 10-fold serial 




onto YPAD containing paromomycin (5mg/ml) or anisomycin (25 mg/ml). To test 
sensitivity to Sparsomycin, filter discs with water, 20µg and 30µg Sparsomycin 
respectively were placed on a lawn of WT and mutant cells. The size of killer zones for 
each disc was observed. Growth curves were generated in quadruplicate with a Synergy 
HT micro-plate reader utilizing the KC4 software package (Bio-Tek Instruments, Inc., 
Winooski, VT). Yeast growth at 30°C was measured in 96-well plates beginning with 0.1 
ml cultures of cells in YPAD medium diluted to OD595=0.05.Cultures were subjected to 
constant high-intensity shaking and automatic OD595 readings were taken of each well at 
20-min intervals for 40h. Duplicate cultures were independently assayed twice and the 
four readings were averaged for each time point. 
Translation fidelity assays 
The dual luciferase reporter plasmids pYDL-control, pYDL-LA, pYDL-Ty1, 
pYDL-UAA, pYDL-AGC218 and pYDL-TCT218 were employed to monitor programmed 
-1 ribosomal frameshifting, programmed +1 ribosomal frameshifting, suppression of 
UAA, and suppression of an AGC near-cognate serine codon and a TCT non-cognate 
serine codon in place of the cognate AGA codon in the firefly luciferase catalytic site, 
respectively273–277. The reporters were expressed from high-copy URA3-based plasmids 
(pJD375, pJD376, pJD376, pJD431, pJD642, pJD643).  Assays were performed as 
previously described277. Sample readings were collected using a GloMax Multi-





Sucrose density gradient fractionation experiments were performed by growing 
yeast cells in YPAD to mid-log growth phase (OD595 of 0.6-1.0). To generate polysome 
profiles, cycloheximide was added to cultures to a final concentration of 0.1 mg/ml and 
cultures were placed on ice for 10 min. Cells were pelleted by centrifugation and washed 
with polysome lysis buffer (20 mM Tris–HCl pH 7.0 at room temperature, 50 mM KCl, 
12 mM MgCl2, 1 mM DTT, 200 µg/ml cycloheximide). Cells were resuspended in 
polysome lysis buffer and disrupted using glass beads (dia 0.5mm) im two 2-min pulses 
using a Min-beadbeater. Lysates were clarified by centrifugation, and aliquots of 7.0 
absorption units at OD260 were frozen at -80°C. Aliquots were layered on top of 10.5 ml 
7–47% sucrose gradients (polysome lysis buffer with 15–55% weight/volume sucrose). 
Gradients were centrifuged at 17,000 rpm for 16 hours at 4°C using a Beckman Coulter 
SW41Ti rotor. After centrifugation, samples were continuously monitored at 254 nm 
using an ISCO gradient fractionator Model UA-5. 
Ribosome purification 
Chromatographic purification of yeast ribosomes was performed as described 
previously259. Lysates of mid-log phase yeast cells were clarified by low-speed 
centrifugation and supernatants were chromatographically purified (Binding buffer- 20 
mM HEPES-KOH pH 7.6, 10 mM MgCl2, 60 mM NH4Cl, 2 mM DTT, 1 mM PMSF; 
Elution Buffer- 20 mM HEPES-KOH pH 7.6, 10 mM MgCl2, 60 mM NH4Cl, 2 mM 
DTT, 1 mM PMSF, 500 mM KCl, 0.5 mg/ml heparin). Remaining tRNAs were cleared 




salt cushion buffer (20 mM HEPES-KOH pH 7.6, 60 mM NH4Cl, 500 mM KCl, 10 mM 
Mg(OAc)2, 2 mM DTT, 25% glycerol) by ultracentrifugation, and subsequently washed 
and re-suspended in low-salt storage buffer (50 mM HEPES-KOH pH 7.6, 50 mM 
NH4Cl, 5 mM Mg(OAc)2, 1 mM DTT, 25% glycerol). Residual salt was removed from 
the re-suspended ribosomes by dialyzing against low-salt storage buffer. 
Aminoacylation of tRNA
Phe 
Recombinant His-tagged Yeast Phenyalanyl-tRNA synthetase (yPheRS) was 
expressed in E. coli using an inducible system278. pQE32- expressing the alpha and beta 
subunits of yPheRS as a fusion protein yPheRS (a generous gift from Dr. David Tirrell, 
California Institute of Technology) was transformed into E. coli strain SG13009 [pREP4] 
(Qiagen). Transformed cells were grown in 2xYT media containing 100µg/ml 
Carbenicillin and 35µg/ml Kanamycin to 0.6 O.D.595 and protein expression was induced 
with 1mM isopropy--D-thiogalactopyranoside (IPTG). Cells were harvested after 4 
hours and the His-tagged protein was purified over nickel-NTA agarose affinity 
purification resin under native condition according to manufacturer’s protocol (Qiagen). 
Imidazole and high salt in the elution buffer were removed by dialyzing against storage 
buffer (50mM Tris-HCl, pH 7.5, and 1mM DTT) using Amicon ultra 50kDa columns. 
The 3’-terminal CCA ends of yeast tRNAPhe (obtained from Sigma-Aldrich) were 
repaired in reactions containing 20mM Glycine-NaOH, pH 9.0, 10mM MgCl2, 16µM 
tRNA, 160µM CTP, 160µM ATP using tRNA terminal nucleotidyl transferase purified 
from yeast by gel filtration and ion-exchange chromatography (300mM KCl fraction) of 




ethanol precipitation. Yeast tRNAPhe was aminoacylated in a 4ml reaction mixture 
containing 16µM tRNAPhe, 40µM [14C]Phe, 10mM ATP, 100mM HEPES-KOH 
(pH=7.6), 9mg yPheRS (1AU/250mg) 10mM KCl, 20mM MgCl2 and 1mM DTT. 
Charged tRNAs were precipitated in 70% ethanol, pelleted and dissolved in 3mM 
CH3COONa, pH 5.2 and purified by HPLC as previously described
280. N-Ac[14C] Phe-
tRNAPhe was synthesized by adding 400µl acetic anhydride at the end of aminoacylation 
reactions and incubated for one hour twice. Modified tRNAs were precipitated and 
purified by HPLC as above. 
Assays of Ribosome and tRNA interactions 
Determination of steady-state binding constants for tRNAs were performed as 
previously described259,281 with modifications. To monitor [14C] Phe-tRNAPhe binding to 
the A site, ribosomes were pre-activated in binding buffer containing polyU and 
deacylated tRNAPhe. Ternary complex was preassembled using HPLC-purified [14C] Phe-
tRNAPhe, GTP, and soluble ammonium sulfate fraction containing yeast elongation 
factors282. Binding reactions containing ribosomes (33.33 nM) and two-fold serial 
dilutions of ternary complexes (0–128 pmoles) were filtered through nitrocellulose filters. 
Similar assays to monitor binding of Ac-[14C] Phe-tRNAPhe to the ribosomal P site were 
performed using preactivated ribosomes incubated with serial dilutions of HPLC-purified 





Peptidyltransferase activity assays were carried out as previously described259. 
Complex C [ribosome-poly(U)-AcPhe-tRNA] was formed in 400µl of binding buffer 
(80mM Tris–HCl, pH 7.4, 160mM ammonium chloride, 11mM magnesium acetate, 2mM 
spermidine and 6mM -mercaptoethanol 500pmol ribosomes, 0.4mg/ml poly(U) and 
700pmol Ac-[14C]Phe-tRNAPhe). Mixtures were incubated for 20min at 30°C and then 
placed on ice. Complexes were purified from free Ac-[14C]Phe-tRNAPhe by centrifugation 
through a glycerol cushion (0.5ml; 20% glycerol in binding buffer by centrifugation at 
50,000rpm for 2h in MLS 50 rotor). Ribosome pellets were rinsed twice with 1ml of 
binding buffer and suspended in 1.15ml of binding buffer. For puromycin reactions, 
1.15ml of complex C extract was pre-incubated at 30C for 5min, and reactions were 
initiated by adding pH neutralized puromycin to final concentrations of 10mM. Aliquots 
of 100µl were removed, and reactions were terminated at the indicated time intervals by 
addition of 100µl of 1.0N NaOH. Reaction products were extracted with 0.4ml of ethyl 
acetate, 0.2ml of organic phase was transferred to scintillation vials, and radioactivity 
was determined by scintillation counting. A 50µl aliquot of initial reaction mixture was 
also transferred to scintillation vials, and total radioactivity (N0) was determined. 
Controls without puromycin were included in each experiment, and the values obtained 
were subtracted as background. The percent of the bound Ac-[14C]Phe-tRNAPhe 
converted to Ac-[14C]Phe-puromycin was corrected with the extent factor α (determined 
if complex C were allowed to react for 1h; C0 = αN0), as described earlier (ref,ref). The 




apparent rate constant of entire course of reaction at a given concentration of puromycin) 
were calculated by using Graphpad Prism software. 
Ribosome protein interactions 
6xHis-tagged eEF2 was purified from TKY675 yeast cells (kindly provided by Dr 
T. Kinzy) as previously described283 with the following modifications. EDTA was added 
to 5mM to eluted eEF2 just before dialysis to bind leached Ni2+ ions and prevent 
precipitate formation during dialysis due to aggregation of His-tagged protein. eEF2 
concentration was determined by [14C]ADP-ribosylation with diphtheria toxin.  For 
eEF2-binding experiments, reaction mixes (50µl) containing 5pmol of salt washed 80S 
ribosomes and various concentrations of 6xHis-tagged eEF2 in binding buffer (50mM 
Tris–HCl, pH 7.5, 50mM ammonium acetate, 10mM magnesium acetate, 2mM DTT, 
100mM GDPNP) were incubated for 20min at room temperature. Estimation of bound 
eEF2 was carried out as follows by assuming that ribosome bound eEF2 is not 
susceptible to ADP-ribosylation by diphtheria toxin284–286. Free (unbound) eEF2 was 
estimated by ADP-ribosylation of eEF2: 100pmol [14C] NAD+ and 0.2mg of diphtheria 
toxin were added to each reaction mix and incubated for 30min at 30°C. Total eEF2 in 
each reaction mix was determined by ADP-ribosylation reaction after bound eEF2 was 
released by adding EDTA to 10mM. Reaction mixes were precipitated with TCA, and 
amounts of [14C]ADP-ribosylated eEF2 were determined by liquid scintillation counting. 
Control values (lacking diphtheria toxin) were subtracted. Ribosome bound eEF2 was 
calculated by subtracting free values from total amount.Kd  values were determined 




rRNA Structure probing analysis 
hSHAPE287 of rRNA with 1M7 was performed as described242 using the 
following primers: 969 and 1780 in the SSU, and 25-2, 1466, 2632, 2836, 25-7, and 3225 
in the LSU. Briefly, rRNA from chemically treated wild type and mutant ribosomes was 
extracted and extension reactions performed using fluorescently labeled primers, 
followed by fragment analysis using capillary electrophoresis. Data were analyzed using 
SHAPEFinder288. For kethoxal studies, 25 pmoles of purified ribosomes in a 50 µl 
volume were treated with 1 µl of a 4% kethoxal solution (in pure ethanol), or 1 µl of 
ethanol as control, and incubated for 10 min at 30°C. Reactions were stopped by the 
addition of one half volume of stop solution (150mM sodium acetate, 250mM potassium 
borate), followed by ethanol extraction and extension reactions were performed as 
described above using primer 969. Scored data were mapped onto 3.0 Å resolution yeast 
ribosomes23 using pymol.  
mRNA Abundance and Telomere length assay. 
Quantitative PCR experiments to assay mRNA abundance were carried out as 
described182. Similar methods were used to quantify telomere length in yeast cells. 
Genomic DNA was isolated from mid-logarithmic cell cultures as previously 
described269. Quantitative polymerase chain reactions to determine yeast telomere content 
(T) relative to the single-copy reference gene SGS1 (S) were performed on serially 
diluted DNA using the Bio-Rad iTaqTM Universal SYBR Green system utilizing primer 
pairs complementary to telomere repeats (Table S2), and cycle threshold values were 




experimental replicates at each of three DNA concentrations (100, 200, and 400 ng). The 





Chapter 4: Conclusions and Future Direction 
Summary 
Protein synthesis is an extraordinarily complex and highly regulated process. 
There can be two possible layers of regulatory controls acting in protein synthesis: the 
synthesizing machinery and the template molecule. Here we have shown that ribosomes 
the protein synthesis machine for cells are very sensitive to small changes in their 
component “gears” and can very easily malfunction if not break down.  
Here we demonstrated that the universal two subunit identity of ribosomes and 
their continuous intersubunit rotation is of prime importance for protein synthesis. It is 
through this rotational capacity that the ribosomes are able to use the same binding 
platform for a variety of ligands which include tRNAs, initiation factors, elongation 
factors, release and recycling factors, rescue factors like UPF1 etc. Interestingly, the same  
ribosomes that can so strongly differentiate between cognate, near-cognate and non-
cognate tRNAs at the time of accommodation, allow the binding of proteins that are 
merely mimics of tRNA structures displaying some a “temporal specificity” towards their 
ligands. This capacity to temporally distinguish between its ligands comes from within 
the ribosomes, from its 4 rRNAs and its 80 proteins. The chemical properties of rRNAs 
and r-proteins do not just keep the machine working but also provide it with the 
selectivity. In solution, 80S ribosomes have an intrinsic capacity to have intersubunit 
rotation. Several small contact points between the subunits at the interface called 




as tiny tangled springs with magnetic forces (analogy for attractive and repulsive 
electrostatic forces on the subunit interphase) embedded on two interfacing surfaces. 
When these surfaces rotate from one state to another because of the magnetic forces, the 
springs (analogous to several r-protein c-terminals embedded into the opposite subunit) 
store the elastic potential energy in order to make the surface rotate back. When the 
surface rotates back to unrotated state, the magnetic force is still at work and possibly 
another set of springs that make the surfaces to rotate against each other again. If some of 
these springs break or lose their elasticity (analogous to mutations in ribosomal 
components), the rotational equilibrium will be hampered and the surfaces lose their 
dynamic rotational equilibrium or experience a shift in it. So does the ribosome. 
The ribosome functionally depends upon its ability to rotate back and forth. It 
transits through several rotated states during elongation cycle. The two extremes of these 
states are called rotated and unrotated. Through mutants of uL2 we have demonstrated 
that there is a direct relationship between rotational status of the ribosome and ligand 
selection. Ribosomes stabilized in the rotated state have a higher affinity for the 
translocase eEF2, and lower than usual affinity for ternary complex. This finding explains 
the unidirectional nature of the elongation cycle.  
Having reduced affinity towards cognate ternary complex, mutant ribosomes also 
lose their selectivity. The selection of correct ligand also heavily depends upon a delicate 
series of kinetic balances. Deleterious mutations in r-proteins can disrupt these parameter 
and cause structural changes that modify the allosteric information exchange pathways 




towards the rotated state of ribosomes lead to variety of instances of increase in 
translational fidelity defects. We have proposed a kinetic model to explain the correlation 
between rotational equilibrium shift and abrogated translation fidelity (figure 43). This 
model is based on the findings of elegant biochemical studies that have detailed the 
parameters underlying the high fidelity selection of cognate tRNA. As discussed before, 
the initial selection of tRNA is based on the rapid dissociation of non-cognate tRNA after 
initial binding, demonstrated by their high dissociation rates (~400 times cognate tRNA). 
However a shift in equilibrium towards the rotated state leads to disproportionately 
increase the rate of dissociation of cognate tRNAs thus resulting in reduced ability to 
discriminate between the cognate and near-cognate ternary complexes. 
Mutations in ribosomal proteins do not just affect the structural details and ligand 
affinities of the ribosomes. They can have severe and biologically relevant effects on 
gene expression. Non- canonical translation pathways are of great interest for studying 
the effect of ribosomal defects on specific mRNA templates expressed by special 
mechanisms like programmed ribosomal frameshift, Stop codon readthrough, or 
incorporation of missense codons. Rotated ribosomes with hybrid state tRNAs have also 
been shown to be substrates for -1PRF. We showed that mutations in the intersubunit 
bridge forming residues of uL2 display high rates of frameshifting in both L-A virus 
directed frameshifting signal as well as -1PRF signals in the yeast EST1, EST2 and STN1 
mRNAs. In eukaryotic cells, -1 PRF signals can act as mRNA destabilizing agents which 
can affect cellular pathways involved in homeostasis. We demonstrated here that mutants 




mRNAs of involved genes. These genes are important for telomere maintenance and we 
observed decreased abundance of telomere repeats for the uL2-mutant.  This is an 
important finding because we directly showed that mutations in ribosomes lead to altered 
gene expression and affected the telomere length in cells. 
Medical relevance and Future Direction 
Once we have established that ribosomal components are regulating gene 
expression through several molecular pathways, there are many avenues to consider the 
importance of ribosomal proteins in health and well-being. 
A fairly newly characterized class of disorders called “ribosomopathies” has 
gained the attention of researchers studying translation. These are genetic disorders 
associated with mutations in ribosomal biogenesis factors or ribosomal proteins. 
Ribosomal proteins act as biogenesis factors also, as many of them bind to the pre-rRNA 
in its nascent unprocessed phase and assist in the proper assembly of ribosome from the 
very start. Mutations in any of these proteins can obviously be devastating for ribosome 
biogenesis and all the processes downstream, like ribosome export, protein synthesis and 
overall homeostasis. Since, ribosome biogenesis and translation are so fundamentally 
important for growth and viability, it would be expected that mutations in genes coding 
these proteins should be inviable. However, surprisingly ribosomopathies display tissue 
specific disease proclivities, bringing to notice the notion of “specialized ribosomes”. 
Specialized ribosomes form a task force of special translation machinery geared towards 
the translation of specific mRNAs expressed only in specific tissue types either by 




specifically abrogated the translation of Homeobox mRNAs without affecting global 
protein synthesis206. A variegated pattern of ribosomal protein expression in the different 
parts of a mouse embryo was observed at different stages of development. Thus 
ribosomes vary tissue-specifically and thus deficiency in ribosomal proteins can affect 
one tissue type more than others. Possible cis-acting features of Homeobox mRNAs may 
indispensably require RPL38 for translation.  Inability to translate the tissue specific 
mRNAs as a result of mutations in genes coding for ribosomal proteins can be the seed 
cause for tissue specific ribosomopathies. 
Ribosomopathies are generally hypoproliferative disorders like anemia, because 
of too few ribosomes to fulfill cellular demands. However, patients with diseases like 
Diamond Blackfan anemia also have predisposition to occurrence of tumors and cancers. 
It is elusive how a hypoproliferative disorder turns into a hyperproliferative one. Here the 
study of uL2 mutants in yeast makes an attempt at explaining this transition. Ribosomes 
with mutant proteins showing high translation fidelity defects can explain the onset of 
cancer in ribosomopathies. Figure 46 suggests a flowchart of disease progression in 
ribosomopathies. Mutation in ribosomal proteins and biogenesis factors slow down a 
steady production of ribosomes in the cell leading to slow growth and more complex 
phenotypes like inefficient organ development in complex organisms. This phenotype 
marks the onset of ribosomopathies in individuals. However slowly, some ribosomes 
escape the strong cellular surveillance and participate in translation. If there are mutations 
in ribosomal proteins, these ribosomes are likely to be inefficient in performing protein 




above, such alterations can be deleterious to the translation of tissue specific mRNAs and 
cause tissue specific diseases. 
 
Figure 46 Model describing the disease progression and cancer onset in 
ribosomopathies 
Altered gene expression further slows down cell growth and can lead to cellular 
stress. Stress causes appearance of new mutants which suppress the slow growth 
phenotype of the original mutation and accelerate cellular proliferation. Such suppressor 
mutations can have oncogenic properties236,289. These new mutations allow the cells to 






























bypass cellular surveillance leading to hyperproliferative phenotype characteristic of 
cancers. 
In a recent study published by our research group, it was demonstrated that 
cellular -1PRF leads to destabilization of the coding mRNA 162,181 by recruiting the 
nonsense mediated mRNA decay pathway (NMD) or No-go decay pathway (NGD). 
Mutants of ribosomal proteins often show increased instances of -1PRF, and bring down 
protein synthesis. Another study has demonstrated a programmed translation readthrough 
event in human cells that leads to a synthesis of a longer variant of a protein called 
Vascular Endothelial Growth Factor (VEGF) with antiangiogenic properties163. Both of 
these studies have reported possible target mRNAs which can be affected by mutant 
ribosomes. We demonstrated here that ribosomes carrying mutant L2 show increased 
rates of –1PRF and UAA readthrough. Such mutant ribosomes can affect gene expression 
by destabilize the mRNA abundance by triggering NMD or NGD in mRNAs containing -
1 PRF signals. In case of the VEGF mRNA, ribosomes displaying higher rates of 
translational readthrough events produce higher amounts of the longer protein with 
antiangiogenic properties. The antiangiogenic property is useful in inhibiting the tumor 
progression as shown by Sandeepa et al.163. However, the same property can be 
deleterious in the developmental stages of an organism and can be the underlying cause 
of certain ribosomopathies. 
 It can thus be useful to target the NMD machinery in order to slow the mRNA 
degradation in mutants with high -1PRF effeciencies. Small molecule inhibitors of -1PRF 




disorders of ribosomal proteins, high throughput studies of tissue specific elements 
involved in disease progression are required. Such studies may help finding specific 
targets of mutants ribosomes at the level of single cell, tissue or whole organism. 
This study provides a kinetic model linking the rotational equilibrium of the 
ribosomes to their ability to discriminate between cognate and near-cognate tRNAs. uL2 
is a core ribosomal protein and essential for peptidyltransferase function of the ribosome. 
Given the essential nature of uL2, for ribosome function, it is less likely to isolate disease 
causing mutants of L2 that survive to the symptomatic stage. This study nevertheless 





Appendix 1: Yeast strain list  
Strain Genotype 
5X47 MATa/MATa his1/+ trp1/+ ura3/+ K- 
yJD1269 




A HN M1] pRPL2A-URA3 
yJD1315 




A HN M1] pRPL2A-LEU2 
yJD1676 




A HN M1] pRPL2A(H139-E143A)-LEU2 
yJD1677 




A HN M1] pRPL2A(D176A)-LEU2 
yJD1678 




A HN M1] pRPL2A(K177A)-LEU2 
yJD1679 




A HN M1] pRPL2A(V148A)-LEU2 
yJD1680 




A HN M1] pRPL2A(G138A)-LEU2 
yJD1681 




A HN M1] pRPL2A(L245-S249A)-LEU2 
yJD1682 




A HN M1] pRPL2A(H139-P141A)-LEU2 
yJD1683 




A HN M1] pRPL2A(D142-E143A)-LEU2 
yJD1684 




A HN M1] pRPL2A(P108-E109A)-LEU2 
yJD1685 




A HN M1] pRPL2A(G110-T111A)-LEU2 
yJD1686 




A HN M1] pRPL2A(K155A)-LEU2 
yJD1687 




A HN M1] pRPL2A(G248-K254A)-LEU2 
yJD1688 




A HN M1] pRPL2A(248-254)-LEU2 
yJD1689 




A HN M1] pRPL2A(V145A)-LEU2 
yJD1690 




A HN M1] pRPL2A(R147A)-LEU2 
yJD1691 




A HN M1] pRPL2A(R147-V148A)-LEU2 
yJD1692 









Appendix 2: List of synthetic oligonucleotides 























































































Appendix 3: Genetic analyses of uL2 basic extension loop mutants 
 
Figure 47 rpL2A basic extension loop mutants promote various phenotypic defects.  
Residues in the basic extension domain of L2 were replaced by aminoacids covering the 
whole range of biochemical properties. (A) Ten-fold serial dilutions of cultures of 
indicated S.cerevisiae strains were spotted on rich medium and incubated for 48 hours at 
30°C, 15°C, and 25µg/ml Anisomycin (30°C) to score for growth, cold and heat 
sensitivity respectively. (B) “Killer” virus phenotypes: The Killer+ phenotype is scored 
by the presence of a halo of growth inhibition around wild-type colony. Lack of the halo 
around colonies expressing the N214F and N214D L2 mutants indicates the Killer- 




Appendix4: Biochemical and functional analyses of uL2-basic 
extension mutants 
 
Figure 48 Mutations of uL2 basic extension domain affect peptidyl-tRNA binding in 
the P-site 
A.  Single site binding isotherms N-Ac-Phe-tRNAPhe to the P-site of ribosomes isolated 
from wild-type, rpl2- N214F, rpl2-N214D, rpl2-H215E and rpl2-Y133A cells. B. N-Ac-
Phe-tRNAPhe binding Kds calculated using ligand depletion model (Graphpad Prizm). 






Figure 49 Polysome profiles of cells expressing WT and mutant uL2. 
Polysome profiles were generated by Sucrose density gradient fractionation of 
cycloheximide arrested cell lysates of WT and mutant rpL2A expressing strains of yeast. 
The first two peaks stand for 40S and 60S subunits respectively, the third peak is 80S 
ribosome and the subsequent peaks represent two or more ribosomes present on the same 
mRNA. In WT cells, the ratio 40S:60S s about 1, while in mutants the 60S is peak is 
significantly lowered due to ribosome biogenesis defects. Shoulders to regular peaks are 
called half-mers and they represent subunit joining defects in translation or lack of 






Appendix 5: Contributions to other Projects 
1. Ribosomal frameshifting in the CCR5 mRNA is regulated by miRNAs and the 
NMD pathway. (Nature(2014) doi:10.1038/nature13429) 
 
The CCR5 sequence promotes efficient frameshifting.   
a. Measurement of -1 PRF in HeLa cells.  -1 PRF efficiency using the 
dulaluciferase reporters was monitored in HeLa cells.  Error bars denote an 





b. Efficient -1 PRF promoted by the CCR5 sequence in vitro.  Autoradiogram of 
in vitro translation reaction using synthetic mRNAs harboring CCR5 or HIV-1 
derived -1 PRF signals.  Green arrows denote 0-frame encoded products. Red 
arrows denote -1 PRF encoded peptides.  RT indicates the readthrough control.  
Percent -1 PRF promoted by CCR5 and HIV-1 frameshift signals is indicated 
below lanes.  
c. MSMS spectrum of Ac-TSRIPVVHAVFALKSQDGHLWGG (2-24) AspN 
proteolytic fragment containing CCR5 fusion peptide. N-terminally acetylated 
leader peptide sequence is colored blue, CCR5-derived 0-frame sequence 
beginning at V94 is red, and CCR5 -1 frame encoded sequence beginning after 
L101 is colored green. 
d. Ribosome profile of the CCR5 mRNA mined from Hsieh et al. Top panel: 
Locations of the -1 PRF signal and -1 frame termination codon are indicated.  
Bottom panel: profiling data at the slippery site (indicated in capital letters) at 
single nucleotide resolution. Ribosomes arrested in the three different reading 
frames are color coded. 
 
Computationally identified putative -1 PRF signals cloned into dual-luciferase reporters 
were assayed in HeLa cells Numbers in hIL8Rα and hIL22Rα denote the nucleotide 
positions of the beginning of the slippery sites in the native mRNAs.   Error bars denote 































































2. rRNA Pseudouridylation defects affect ribosomal ligand binding and 




A) Single-site isotherms of eEF1A stimulated binding of [14C]Phe-tRNAPhe (2-fold 
serial dilutions from 1 to 128 pmoles) to the A sites of 20 pmoles of poly(U) primed 
ribosomes preloaded with tRNAPhe in their A sites. 
(B) Single-site isotherms of Ac-[14C]Phe-tRNAPhe (2-fold serial dilutions from 1 to 128 
pmoles) to P sites of 20 pmoles of poly(U) primed ribosomes. Steady-state Kd values and 
standard deviations for each sample are indicated. All tRNA binding assays were 
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